Top ▲
Ligand name | ID | Synonyms | |||||||
A | Back to top | ||||||||
A-71378 | 894 | A 71378, A71378 | |||||||
A-71623 | 858 | A 71623, A71623, L-phenylalaninamide | |||||||
A-71915 | 4856 | A 71915, A71915, H-3048 | |||||||
A8Δ71-73 | 5780 | ||||||||
abaloparatide |
![]() |
8299 | BA058, Tymlos® | ||||||
abarelix |
![]() |
1188 | Plenaxis®, PPI 149, R 3827 | ||||||
abatacept |
![]() |
![]() |
6891 | BMS-188667, CTLA4-IgG4m, Orencia®, RG-1046, RG-2077 | |||||
A(4-24)(B7-24)H2 | 8346 | A(4-24)(B7-24)H2 relaxin | |||||||
A(4-24)(B7-24)H2 chain A | 8347 | A(4-24)H2 relaxin | |||||||
A(4-24)(B7-24)H2 chain B | 8348 | (B7-24)H2 relaxin | |||||||
abicipar pegol | 8371 | AGN-150998, MP0112 | |||||||
ABS-201 | 5308 | ABS 201, ABS201, HPI-201, HPI201, KK13 | |||||||
ABS-212 | 5307 | ABS 212, ABS212 | |||||||
Abz-Ser-Pro-Tyr(NO2)-OH | 5132 | o-aminobenzoyl-Ser-Pro-Tyr(NO2)-OH, TBC5182 | |||||||
AC-178,335 | 2065 | AC 178335 | |||||||
AC187 | 689 | AC 187, AC-187, acetyl-(Asn30,Tyr32)-calcitonin8-32, salmon calcitonin (8-32) reduced | |||||||
Ac-c[Cys-Glu-His-D-Phe-Arg-Trp-D-Cys]-Pro-Pro-Lys-Asp-NH2 | 1342 | ||||||||
Ac-[13C,15N]PGP |
![]() |
![]() |
12599 | ||||||
[Ac-D-2Nal1,D4CPA2,D-3Pal3,6,Leu8, D-Ala10]GnRH-II | 5583 | ||||||||
Ac-GRP-(20-26)-methylester | 625 | N-acetyl-GRP-(20-26)-ethylester | |||||||
[Ac-His1]PACAP-27 | 2263 | [Ac-His1]pituitary adenylate cyclase activating polypeptide-27 | |||||||
[125I][Ac-His1]PACAP-27 |
![]() |
![]() |
2260 | [125I]-[Ac-His1]pituitary adenylate cyclase activating polypeptide-27 | |||||
Ac-hMCH-(6-16)-NH2 | 1290 | hAc-MCH(6-16)-NH2, human Ac-MCH6-16-NH2 | |||||||
A(Δ10/15C)INSL3 | 8332 | ||||||||
aclerastide | 8300 | DSC-127, DSC127, NorLeu3-A(1-7) | |||||||
Ac-Lys-[MeAla6,Leu8,des-Arg9]bradykinin | 651 | N-acetylated-[Lys,MeAla6,Leu8,des-Arg9]bradykinin, Ac-[MeAla6,Leu8,des-Arg9]kallidin | |||||||
AcPhe-Orn-Pro-D-Cha-Trp-Arg | 3853 | AcF[OP-D-Cha-Wr] | |||||||
Ac-Phe-Trp-Ala-His(τBZL)-Nip-Gly-Arg-NH2 | 6191 | ||||||||
Ac-RHYPLWR | 8380 | ||||||||
Ac-RYYRIK-NH2 | 1679 | ||||||||
Ac-RYYRWK-NH2 | 1680 | ||||||||
Ac-SDKP |
![]() |
10060 | goralatide, seraspenide | ||||||
A(C10/15S)INSL3 | 8331 | ||||||||
ACTH-(11-24) | 1332 | ACTH (11-24), adrenocorticotropic hormone (11-24) | |||||||
ACTH-(1-24) | 1330 | ACTH (1-24), adrenocorticotropic hormone (1-24) | |||||||
[125I]ACTH-(1-24) |
![]() |
![]() |
3767 | [125I]-ACTH(1-24), [125I]-adrenocorticotropin(1-24) | |||||
[Ac-Tyr1, D-Arg2]GHRH-(1-29)-NH2 (human) | 1125 | ||||||||
adaptavir | 11692 | D-Ala-peptide T-amide, DAPTA | |||||||
AF12198 |
![]() |
4861 | AF 12198, AF-12198 | ||||||
A(4-24)(F23A)H2 | 8349 | ||||||||
afamelanotide |
![]() |
1324 | α-NDP-MSH, [Nle4,dPhe7]α-MSH, CUV-1647, CUV1647, NDP-MSH, Scenesse® | ||||||
aflibercept |
![]() |
6786 | AVE0005, Eylea®, VEGF Trap, Zaltrap®, ziv-aflibercept | ||||||
AFT-II | 2613 | neurotoxin-2, Toxin AFII, Toxin AFT-II | |||||||
ω-agatoxin IIIA | 2528 | omega-Aga-IIIA, Omega-agatoxin-Aa3a | |||||||
ω-agatoxin IVA | 2529 | omega-Aga-IVA, Omega-agatoxin-Aa4a | |||||||
ω-agatoxin IVB | 2530 | Omega-agatoxin-Aa4b | |||||||
A(10-24)INSL3 | 8330 | ||||||||
A(9-26)INSL3 | 8329 | ||||||||
AL-78898A |
![]() |
9219 | 4(1MeW), POT-4 | ||||||
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-34)-NH2 | 5573 | [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-hPTH 1-34-NH2, M-PTH(1-34) | |||||||
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-21)-NH2 (human) | 5575 | [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]hPTH-(1-21)-NH2, [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-PTH 1-21-NH2 (human), M-PTH(1-21) | |||||||
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-28)-NH2 (human) | 5574 | [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-hPTH 1-28-NH2, [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-PTH 1-28-NH2 (human), M-PTH(1-28) | |||||||
[Ala1,12,Aib3,Gln10,hArg11,Trp14]PTH-(1-14)-NH2 | 5576 | [Ala1,12,Aib3,Gln10,hArg11,Trp14]-hPTH 1-14-NH2, [Ala1,12,Aib3,Gln10,hArg11,Trp14]-PTH 1-14-NH2 (human), M-PTH(1-14) | |||||||
[Ala31,Aib32]NPY | 1560 | ||||||||
[Ala31,Aib32]NPY (pig) | 1522 | ||||||||
[Ala11, D-Leu15]orexin-B | 1700 | ||||||||
[Ala6, D-Trp8]galanin-(1-15)-ol | 6146 | ||||||||
[Ala1,3,11,15]ET-1 | 3837 | [Ala1,3,11,15]endothelin-1 | |||||||
[125I][Ala1,3,11,15]ET-1 |
![]() |
![]() |
3760 | [125I]-[Ala1,3,11,15]endothelin-1, [125I][Ala1,3,11,15]endothelin-1 | |||||
alafosfalin |
![]() |
9503 | alaphosphin | ||||||
[2Ala]-galparan | 6098 | ||||||||
β-Ala-Lys-AMCA |
![]() |
9501 | β-alanyl-lysyl-N-7-amino-4-methylcoumarin-3-acetic acid, Beta-Ala-Lys-N(epsilon)-AMCA | ||||||
[βAla8]neurokinin A-(4-10) | 2112 | [βAla8]neurokinin A (4-10) | |||||||
alarelin | 9342 | ||||||||
[Ala11,22,28]VIP | 2278 | [Ala11,22,28]vasoactive intestinal peptide | |||||||
albiglutide |
![]() |
7386 | Eperzan®, GSK716155, Tanzeum® | ||||||
albutensin A | 10226 | ||||||||
aldafermin | 11546 | M70, NGM-282, NGM282 | |||||||
alefacept |
![]() |
![]() |
6787 | Amevive®, BG 9273, BG 9712, BG-9273, BG-9712, Lfa3Tip | |||||
alglucosidase alfa |
![]() |
7561 | Lumizyme®, Myozyme®, rhGAA | ||||||
ALM201 | 11485 | ||||||||
alpha1-proteinase inhibitor |
![]() |
7487 | A1AT, A1PI, alpha 1-antitrypsin, Aralast®, Prolastin®, serum trypsin inhibitor | ||||||
AlprolixTM |
![]() |
7373 | |||||||
alunacedase alfa | 11320 | APN01, GSK-2586881, GSK2586881, rhsACE2 | |||||||
ALX40-4C | 607 | ALX 40-4C, N-alpha-acetyl-nona-D-arginine amide acetate | |||||||
AM3 | 5635 | DOTA-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-D-Trp-Lys-Thr-Cys) | |||||||
AM-6120 |
![]() |
10119 | AM6120, peptide 41 [PMID: 30346167] | ||||||
amanitin | 4632 | α-amanitin | |||||||
AMG3054 | 9587 | ||||||||
AM-(22-52) (human) | 706 | AM (22-52), human adrenomedullin (22-52) | |||||||
AM-(11-50) (rat) | 704 | AM (11-50), rat adrenomedullin (11-50) | |||||||
AM-(20-50) (rat) | 705 | rat adrenomedullin (20-50) | |||||||
[125I]AM (rat) |
![]() |
![]() |
3768 | [125I]-adrenomedullin, [125I]-AM | |||||
AMT-101 |
![]() |
11645 | |||||||
AMY-101 | 11986 | AMY101, Compstatin 40, Compstatin analog CP40, CP-40, peptide 14 [PMID: 22795972] | |||||||
amyloid β1-16 | 13243 | Aβ(1-16), N-Aβ | |||||||
anakinra |
![]() |
![]() |
6972 | antril, Kineret® | |||||
analog 30 [PMID:18543899] | 5647 | ||||||||
analog 31 [PMID:18543899] | 5648 | ||||||||
analog 32 [PMID:18543899] | 7763 | ||||||||
analog 3 [PMID:18543899] | 5646 | ||||||||
analogue 13: B7-24 | 11918 | ||||||||
anantin | 4866 | ||||||||
andexanet alfa |
![]() |
7576 | Andexxa®, coagulation factor Xa (recombinant), inactivated-zhzo, Ondexxya®, PRT064445, PRT4445, r-antidote | ||||||
[125I]angiotensin-(1-7) (human, mouse, rat) |
![]() |
![]() |
5578 | [125I]ang-(1-7) | |||||
[125I]ANP (human) |
![]() |
![]() |
4845 | [125I]-ANP | |||||
antarelix | 1189 | D-23234, EP 24332 | |||||||
antisauvagine | 931 | [dPhe11,His12]Svg(11-40), antisauvagine-30 | |||||||
[125I]antisauvagine |
![]() |
![]() |
930 | ||||||
AP811 | 4870 | AP 811, AP-811 | |||||||
apamin | 2311 | ||||||||
[125I]apelin-13 |
![]() |
![]() |
602 | ||||||
apelin-13(F13A) | 5354 | ||||||||
APETx-1 | 2609 | Toxin APETx1 | |||||||
APETx2 | 4135 | ||||||||
aponermin |
![]() |
13293 | Shaite® (China) | ||||||
apraglutide | 10685 | CVQ1IAY2G6, FE 203799, FE203799 | |||||||
aprotinin {Sp: Bovine} |
![]() |
6570 | basic protease inhibitor (BPI), BPTI, pancreatic trypsin inhibitor, Trasylol® | ||||||
AR305352 | 7043 | ||||||||
[Arg16]chicken secretin | 3293 | [R16]chicken secretin | |||||||
arginine vasotocin | 2169 | AVT, [Arg8]vasotocin | |||||||
[Arg14Lys15]N/OFQ | 1689 | [Arg14Lys15]nociceptin, [Arg14Lys15]nociceptin/orphanin FQ, [Arg14Lys15]orphanin FQ | |||||||
[Arg19]PTH-(1-34) (human) | 1792 | [Arg19]-PTH 1-34 (human) | |||||||
ARL-15849 | 859 | AR-R 15849, ARL 15849XX, FPL 15849 | |||||||
ASIP [90-132 (L89Y)] | 1327 | agouti-signaling protein [90-132 (L89Y)], agouti-signaling protein[90-132 (L89Y)] | |||||||
astressin | 925 | ||||||||
[125I]astressin |
![]() |
![]() |
924 | ||||||
astressin 2B | 10335 | Astressin2-B, astressin2-B, cyclo(31-34)[DPhe(11),His(12),C(alpha)MeLeu(13,39),Nle(17),Glu(31),Lys(34)]Ac-sauvagine(8-40), peptide 20 [PMID: 12361401] | |||||||
[Asu7,23']β-ANP-(7-28) | 4852 | [Asu7,23']-β-ANP7-28 | |||||||
atacicept |
![]() |
9517 | TACI-Fc, TACI-Ig | ||||||
atosiban |
![]() |
2213 | Antocin®, d[D-Tyr(Et)2,Thr4,Orn8]vasotocin, d[D-Tyr(Et)2,Thr4]OVT, ORF22164, RWJ 22164, Tractocile® | ||||||
ATX-II | 2614 | anemonia viridis toxin 2, Sea anemone toxin II (Anemonia sulcata), toxin ATX-II | |||||||
aTyr 1940 | 8738 | ATYR1940, HRS(1-506), Resolaris | |||||||
AUNP-12 | 10117 | Aur-012, Aurigene NP-12, Aurigene-012, compound #8 [WO2011161699A3] | |||||||
Ava3 | 3855 | ||||||||
Ava5 | 3856 | ||||||||
[Ava9,10,Ava14,15]-Ac-hMCH6-16-NH2 | 1307 | compound 30 [PMID:12009900] | |||||||
avexitide | 13444 | ||||||||
aviptadil |
![]() |
10891 | Invicorp® (aviptadil + phentolamine), Vasoactive intestinal octacosapeptide | ||||||
[3H]AVP (human, mouse, rat) |
![]() |
![]() |
2175 | [3H]arginine vasopressin | |||||
AY77 | 9455 | compound 14 [PMID: 26819675] | |||||||
AYPGKF-NH2 | 4061 | AY-NH2 | |||||||
azapro-3 |
![]() |
9221 | |||||||
B | Back to top | ||||||||
B-10356 | 652 | ||||||||
B1-27 | 11459 | analog 2 [PMID: 32133341] | |||||||
B-9430 | 653 | B 9430, B9430, D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin | |||||||
B-9858 | 654 | B 9858, Lys-Lys-[Hyp3, Igl5, D-Igl7, Oic8]des-Arg9-BK | |||||||
B-9958 | 655 | B9958, des-Arg(9)-BK | |||||||
balixafortide | 11587 | POL-6326, POL6326 | |||||||
barusiban | 10890 | C4.6,S1-cyclo[N-(3-sulfanylpropanoyl)-D-tryptophyl-L-isoleucyl-L-alloisoleucyl-L-asparaginyl-L-2-aminobutanoyl-N-methyl-L-ornithinol], FE 200 440, FE-200440 | |||||||
BASS antagonist | 5644 | BASS antagonist Analog 4 | |||||||
BAY 55-9837 | 2269 | ||||||||
BAY86-7548 |
![]() |
![]() |
11260 | [68Ga]D-Phe6, Stat13, Leu14 Bn(6-14), [68Ga]RM2, Ga-RM2 | |||||
[125I]BAY 55-9837 |
![]() |
![]() |
2281 | ||||||
BBL-454 | 895 | BBL 454, BBL454 | |||||||
BC-254 | 896 | BC 254, BC254 | |||||||
BC-264 | 897 | BC 264, BC264 | |||||||
Bc-III | 2615 | major neurotoxin BcIII | |||||||
BCY15291 | 12820 | ||||||||
[125I]BDNF (human) |
![]() |
![]() |
4846 | [125I]-BDNF, [125I]-brain-derived neurotrophic factor | |||||
beinaglutide |
![]() |
12863 | Feisumei® | ||||||
BeKm-1 | 2610 | neurotoxin BeKm-1, potassium channel toxin γ-KTx 2.1 | |||||||
belatacept |
![]() |
![]() |
6892 | BMS-224818, LEA29Y, Nulojix® | |||||
bempegaldesleukin |
![]() |
10659 | NKTR-214, NKTR214 | ||||||
bevemipretide | 13258 | SBT-272, SBT272 | |||||||
BgK | 2551 | Potassium channel toxin Bgk | |||||||
[125I]BgK (W5Y / Y26F) |
![]() |
![]() |
2565 | ||||||
(B7-33)H2 | 9321 | ||||||||
[125I]BH-AMY (rat, mouse) |
![]() |
![]() |
3770 | [125I]-BH-AMY, [125I]-Bolton Hunter amylin | |||||
[125I]BH-MIT1 |
![]() |
![]() |
8522 | ||||||
[125I]BH-NMB (human, mouse, rat) |
![]() |
![]() |
3771 | [125I]-BH-NMB, [125I]-Bolton Hunter neuromedin B | |||||
[125I]BH-[Sar9,Met(O2)11]SP |
![]() |
![]() |
3769 | [125I]-BH-[Sar9,Met(O2)11]SP, [125I]-Bolton Hunter-[Sar9,Met(O2)11]substance P | |||||
[3H]BH-[Sar9,Met(O2)11]SP |
![]() |
![]() |
3811 | [3H]-Bolton Hunter-[Sar9,Met(O2)11]substance P, [3H]-BH-[Sar9,Met(O2)11]SP | |||||
bihelical apoA-I mimetic peptide 5A |
![]() |
9183 | 5A peptide | ||||||
BIM 23023 | 2032 | ||||||||
BIM 23027 | 2033 | BIM23027 | |||||||
BIM 23030 | 2034 | ||||||||
BIM 23034 | 2035 | DC 13-212 | |||||||
BIM 23050 | 2003 | BIM-23050 | |||||||
BIM 23052 | 2004 | BIM-23052, BIM23052, DC-(23-99) | |||||||
BIM 23056 | 2036 | ||||||||
BIM 23058 | 2068 | ||||||||
BIM 23059 | 2037 | ||||||||
BIM 23060 | 2038 | ||||||||
BIM 23066 | 2039 | ||||||||
BIM 23068 | 2040 | ||||||||
BIM 23127 | 2162 | ||||||||
BIM 23197 | 2041 | ||||||||
BIM 23268 | 2083 | BIM23268 | |||||||
BIM 23295 | 2069 | ||||||||
BIM 23313 | 2084 | ||||||||
BIM 23454 | 2026 | ||||||||
BIM 23627 | 2027 | H-5886, MW 1164 | |||||||
BIM28011 | 3857 | [D-Ala2,Ala8,9,15,27,D-Arg29]hGHRH(1-29)NH2, BIM 28011 | |||||||
BIM 28163 | 1101 | BIM-28163 | |||||||
[125I]BIM23027 |
![]() |
![]() |
3772 | [125I]-BIM 23027, [125I]-BIM23027 | |||||
BIO1211 | 6589 | BIO 1211, BIO-1211 | |||||||
bivalirudin |
![]() |
6470 | Angiomax® | ||||||
BJP-06-005-3 | 11401 | compound 1 [PMID: 32483379], N-(chloroacetyl)-N-methyl-L-phenylalanyl-L-homoprolyl-L-tryptophyl-L-citrulline ethyl ester | |||||||
[3H]BK (human, mouse, rat) |
![]() |
![]() |
3812 | [3H]-BK, [3H]-bradykinin | |||||
blisibimod |
![]() |
9518 | A-623, AGP3 peptibody, AMG 623, Fc-Agp-3 | ||||||
BM213 | 12513 | ||||||||
BM221 | 12514 | ||||||||
BOC-ATE | 2042 | ||||||||
BODIPY® TMR-NMU | 3858 | ||||||||
bombesin | 616 | ||||||||
BOP | 12045 | compound 2 [PMID: 24363056], compound 3 [PMID: 12033947], N-(Benzenesulfonyl)-L-prolyl-L-O-(1-pyrrolidinylcarbonyl)tyrosine | |||||||
[Bpa1,Ile13]motilin (human) | 1452 | ||||||||
[Bpa6,Tyr10]secretin-27 (rat) |
![]() |
![]() |
1154 | ||||||
BP-CCL3 | 752 | BP-LD78α, BP-MIP-1α, photoactivatable macrophage inflammatory protein-1α | |||||||
BPTI-K15R/R17G | 7897 | ||||||||
BQ123 | 997 | BQ 123, BQ-123 | |||||||
BQ 3020 | 3859 | BQ-3020, BQ3020 | |||||||
[125I]BQ3020 |
![]() |
![]() |
1005 | [125I]-BQ3020 | |||||
[3H]BQ123 |
![]() |
![]() |
1003 | [3H]-BQ123, [3H]cyc(DTrp-DAsp-Pro-DVal-Leu | |||||
bremelanotide |
![]() |
10408 | PT-141, PT141, Vyleesi® | ||||||
brimapitide |
![]() |
9101 | AM-111, D-JNKI-1, XG-102 | ||||||
B-R13/17K H2 relaxin | 4371 | AT-001, B13/17K H2 relaxin | |||||||
BT7480 |
![]() |
12060 | BCY11863, BT-7480 | ||||||
bulevirtide |
![]() |
12775 | BLV, formerly Myrcludex B, Hepcludex® | ||||||
α-bungarotoxin | 3964 | ||||||||
[125I]α-bungarotoxin |
![]() |
![]() |
3972 | ||||||
[3H]α-bungarotoxin |
![]() |
![]() |
3981 | ||||||
buserelin |
![]() |
3860 | buserelin acetate, HOE 766, HOE 766A, ICI 123215, Metrelef®, Suprefact® | ||||||
[125I]buserelin |
![]() |
![]() |
1167 | [125I]-buserelin | |||||
Bv8 | 5362 | Bombina variegata protein | |||||||
[Bz-Phe6]U-II (human) | 2159 | human [Bz-Phe6] urotensin-II | |||||||
C | Back to top | ||||||||
C089 | 5779 | ||||||||
C21 | 7037 | ||||||||
C3 | 1291 | ||||||||
C7 | 3861 | galanin(1-13)spantide | |||||||
cagrilintide | 13768 | AM-833, AM833, analogue 23 [PMID: 34288673], NN0174-0833 | |||||||
C5a hexapeptide analogue | 5768 | Phe-Lys-Ala-dCha-Cha-dArg | |||||||
[125I]C3a (human) |
![]() |
![]() |
3773 | [125I]-C3a | |||||
[125I]C5a (human) |
![]() |
![]() |
3774 | [125I]-C5a | |||||
calciseptine | 4149 | ||||||||
calcitonin (salmon) |
![]() |
6973 | CT (salmon), Miacalcin® | ||||||
calpeptin | 11643 | benzylcarbonyl-Leu-nLeu-H, N-benzyloxycarbonyl-L-leucyl-L-norleucinal | |||||||
cANF4-23 | 4892 | des[Gln18,Ser19,Gly20,Leu21,Gly22]ANP4ï¾–23-NH2 | |||||||
cangitoxin II | 7568 | cangitoxin-2, cangitoxin-II, CGTX-II | |||||||
C5apep | 11344 | ||||||||
carbetocin |
![]() |
11169 | Pabal® | ||||||
casoxin C | 10224 | ||||||||
[125I]cathepsin G (human) |
![]() |
![]() |
1017 | [125I]cathepsin G | |||||
CB-182804 | 11003 | CB-182,804, CB182804 | |||||||
CCK-58 {Sp: Dog} | 862 | ||||||||
[3H]CCK-8 (human, mouse, rat) |
![]() |
![]() |
4765 | [3H]-CCK-8 | |||||
[125I]CCL11 (human) |
![]() |
![]() |
794 | [125I]eotaxin | |||||
[125I]CCL16 (human) |
![]() |
![]() |
1275 | [125I]LEC | |||||
[125I]CCL17 (human) |
![]() |
![]() |
3652 | [125I]TARC | |||||
[125I]CCL19 (human) |
![]() |
![]() |
3655 | [125I]ELC | |||||
[125I]CCL1 (human) |
![]() |
![]() |
814 | [125I]I-309, [125I]P500, [125I]TCA-3 | |||||
[125I]CCL20 (human) |
![]() |
![]() |
3654 | [125I]LARC, [125I]MIP-3α | |||||
[125I]CCL21 (human) |
![]() |
![]() |
3656 | [125I]SLC | |||||
[125I]CCL25 (human) |
![]() |
![]() |
3657 | [125I]TECK | |||||
[125I]CCL27 (human) |
![]() |
![]() |
3653 | [125I]CTACK | |||||
[125I]CCL2 (human) |
![]() |
![]() |
762 | [125I]MCAF, [125I]MCP-1, [125I]monocyte chemotactic protein-1 | |||||
[125I]CCL3 (human) |
![]() |
![]() |
763 | [125I]macrophage inflammatory protein-1α, [125I]MIP-1α | |||||
[125I]CCL4 (human) |
![]() |
![]() |
799 | [125I]macrophage inflammatory protein-1β, [125I]MIP-1β | |||||
[125I]CCL5 (human) |
![]() |
![]() |
764 | [125I]RANTES, [125I]regulated upon activation normal T cell expressed and secreted | |||||
[125I]CCL7 (human) |
![]() |
![]() |
765 | [125I]MCP-3, [125I]monocyte chemotactic protein-3 | |||||
[125I]CCL8 (human) |
![]() |
![]() |
766 | [125I]MCP-2, [125I]monocyte chemotactic protein-2 | |||||
[125I]CCL1 (mouse) |
![]() |
![]() |
5546 | ||||||
CCL20-SEAP(His)6 | 809 | LARC fused with secreted alkaline phosphatase, LARC-SEAP(His)6, MIP-3α fused with secreted alkaline phosphatase | |||||||
cenderitide | 9066 | CD-NP | |||||||
cetrorelix |
![]() |
![]() |
1190 | Cetrotide®, SB-075 | |||||
[125I]cetrorelix |
![]() |
![]() |
1186 | ||||||
CGEN-856 | 7041 | P61 | |||||||
CGEN-857 | 7040 | P33 | |||||||
CGEN-855A | 6241 | ||||||||
CGP 23996 | 2005 | CGP-23996, CGP23996 | |||||||
CGP42112 | 3944 | CGP 42112, CGP 42112A | |||||||
[125I]CGP 23996 |
![]() |
![]() |
2022 | ||||||
[125I]CGP42112 |
![]() |
![]() |
594 | [125I]-CGP42112, Cgp 42112B, Cgp-42112A | |||||
α-CGRP-(8-37) (human) | 700 | α-CGRP (8-37) (human), human α-calcitonin gene-related peptide (8-37) | |||||||
[125I]αCGRP (human) |
![]() |
![]() |
3766 | [125I]-αcalcitonin gene-related peptide, [125I]-αCGRP | |||||
[125I]αCGRP (mouse, rat) |
![]() |
![]() |
6567 | ||||||
α-CGRP-(8-37) (rat) | 701 | α-CGRP (8-37) (rat), rat α-calcitonin gene-related peptide (8-37) | |||||||
CH 275 | 2006 | CH-275, desAA1,2,5[D-Trp8,IAmp9]somatostatin-14 | |||||||
charybdotoxin | 2328 | ChTX | |||||||
charybdotoxin-GLU32 analog | 2329 | ChTX-GLU32 | |||||||
[Cha6]U-II-(4-11) | 9439 | ||||||||
chemerin C-terminal peptide | 3422 | bioactive chemerin peptide, chemerin 149-157, chemerin 9, chemerin-9 | |||||||
CHIPS | 3724 | chemotaxis inhibitory protein of S. aureus | |||||||
CHIPS-(28-149) | 5770 | CHIPS28-149 | |||||||
[125I]CHIPS |
![]() |
![]() |
1027 | [125I]chemotaxis inhibitory protein of S. aureus | |||||
[(CH2NH)4,5]secretin | 3755 | [ψ4,5]secretin | |||||||
[125I]chorionic gonadotropin (human) |
![]() |
![]() |
3775 | [125I]CG (human), [125I]-CG, [125I]-chorionic gonadotropin | |||||
cibinetide |
![]() |
9677 | ARA 290, ARA-290, PH-BSP, PHBSP | ||||||
C12-iE-DAP | 9508 | ||||||||
cilengitide | 6597 | EMD-12192, EMD-121974 | |||||||
4-Cl-cinnamoyl-c[DCys-4Pal-DTrp-Orn-Val-Cys]-His-amide | 2161 | ||||||||
[125I]CNP (human) |
![]() |
![]() |
4847 | [125I]-CNP | |||||
C2-NPY (pig) | 1534 | ||||||||
compound 54 | 11898 | ||||||||
compound 6b [PMID: 24999562] | 7927 | ||||||||
compound 25c [PMID: 23747811] | 11641 | ||||||||
compound 3c [PMID: 30360354] |
![]() |
10591 | [As(4-F)F4]-GHRP-6, azasulfuryl-p-fluorophenylalanine-4-[As(4-F)F4]-GHRP-6, H-His-D-Trp-Ala-(4-F)AsF-D-Phe-Lys-NH2 | ||||||
compound 5d [PMID: 25815150] | 9008 | ||||||||
compound 8d [PMID: 24999562] | 7926 | ||||||||
compound 1 [PMID: 25241924] | 7801 | ||||||||
compound 2 [PMID: 11375253] | 1292 | ||||||||
compound 3 [PMID: 16884309] | 11640 | ||||||||
compstatin |
![]() |
9218 | |||||||
conantokin-G | 4161 | conotoxin GV | |||||||
concanavalin A | 4162 | ||||||||
conestat alfa |
![]() |
7627 | rhC1INH, Ruconest® | ||||||
conkunitzin-S1 toxin | 7758 | conk-S1, Kunitz-type conkunitzin-S1 | |||||||
conopeptide Y-PI1 | 7742 | ||||||||
α-conotoxin ArIB | 4007 | ||||||||
α-conotoxin AuIB | 3973 | ||||||||
ω-conotoxin CVIA | 2531 | ||||||||
ω-conotoxin CVIB | 2532 | ||||||||
ω-conotoxin CVIC | 2533 | ||||||||
ω-conotoxin CVID | 2534 | AM-336, AM336, CNSB004, leconotide | |||||||
α-conotoxin GI | 3983 | G1 | |||||||
α-conotoxin-GIC | 4009 | ||||||||
μ-conotoxin GIIIA | 2630 | Geographutoxin I, GTx-I, Myotoxin I | |||||||
ω-conotoxin GVIA | 2535 | ||||||||
α-conotoxin ImI | 3965 | α-CTx ImI | |||||||
α-conotoxin MI | 3999 | ||||||||
α-conotoxin MII | 3970 | ||||||||
[125I]α-conotoxin MII |
![]() |
![]() |
3975 | ||||||
α-conotoxin MII [H9A, L15A] | 4010 | ||||||||
ω-conotoxin MVIIC | 2537 | ω-CTx-MVIIC, SNX-230 | |||||||
ω-conotoxin MVIID | 2538 | SNX-238 | |||||||
α-conotoxin PIA | 3985 | ||||||||
μ-conotoxin PIIIA | 2631 | μ-conotoxin P3.7 | |||||||
α-conotoxin PnIA | 3982 | ||||||||
α-conotoxin RgIA | 4008 | ||||||||
μ-conotoxin SmIIIA | 7567 | ||||||||
α-conotoxin TxIA | 4011 | ||||||||
consomatin Fj1 | 13681 | ||||||||
contulakin-G | 1575 | CGX-1160 | |||||||
corticotropin-releasing factor {Sp: Sheep} | 913 | CRF, corticoliberin, endorpholiberin | |||||||
corticotropin zinc hydroxide |
![]() |
![]() |
6967 | ||||||
cosyntropin |
![]() |
6965 | Cortrosyn® | ||||||
CPN-116 | 11490 | peptide 6b [PMID: 24999562] | |||||||
CPN-219 | 11491 | ||||||||
CPN-223 | 11492 | analogue 8 [PMID: 32721452] | |||||||
CPN-267 | 10380 | analogue 7b [PMID: 28548497], C-terminal core peptide derivative of neuromedin U, bearing (α-Me)Trp2, NMUR1 agonist C7b | |||||||
[125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP |
![]() |
![]() |
3921 | [125I]-[cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP | |||||
CPS4 | 11603 | ||||||||
[125I]CRF (ovine) |
![]() |
![]() |
915 | [125I]corticotropin | |||||
crisantaspase |
![]() |
7347 | asparaginase, Elspar®, Enrylaze®, L-asparaginase, L-asparagine amidohydrolase | ||||||
CTAP | 1635 | ||||||||
[125I]CT (human) |
![]() |
![]() |
3776 | [125I]-calcitonin (Human), [125I]-CT (Human) | |||||
CTOP | 1674 | Ctop-NH2, CTOPA | |||||||
[3H]CTOP |
![]() |
![]() |
12512 | ||||||
CTR-stimulating peptide {Sp: Pig} | 5369 | calcitonin-receptor stimulating peptide, CRSP-1 | |||||||
CT-(8-32) (salmon) | 690 | CT (8-32) (salmon), salmon calcitonin (8-32) | |||||||
[125I]CT (salmon) |
![]() |
![]() |
3777 | [125I]-calcitonin (Salmon), [125I]-CT (Salmon) | |||||
CXCL12-(1-17) | 846 | CXCL12, 1-17, SDF-1, 1-17, stromal cell-derived factor-1, N-terminal fragment | |||||||
CXCL12-(1-9) | 847 | CXCL12, 1-9 | |||||||
CXCL12-(1-9) dimer | 848 | CXCL12, 1-9 dimer, stromal cell-derived factor-1, N-terminal fragment dimer | |||||||
CXCL122 (dimer) | 8535 | ||||||||
CXCL12H25R (monomer) | 8534 | ||||||||
[125I]CXCL10 (human) |
![]() |
![]() |
3660 | [125I]IP-10 | |||||
[125I]CXCL11 (human) |
![]() |
![]() |
3661 | [125I]I-TAC | |||||
[125I]CXCL12α (human) |
![]() |
![]() |
849 | [125I]SDF-1α (human), [125I]stromal cell-derived factor-1α | |||||
[125I]CXCL12β (human) |
![]() |
![]() |
850 | [125I]SDF-1β (human), [125I]stromal cell-derived factor-1β | |||||
[125I]CXCL16 (human) |
![]() |
![]() |
3662 | ||||||
[125I]CXCL1 (human) |
![]() |
![]() |
3677 | [125I]GROα | |||||
[125I]CXCL5 (human) |
![]() |
![]() |
3659 | [125I]ENA-78 | |||||
[125I]CXCL7 (human) |
![]() |
![]() |
3658 | [125I]NAP-2 | |||||
[125I]CXCL8 (human) |
![]() |
![]() |
822 | [125I]IL-8, [125I]interleukin-8 | |||||
[125I]CX3CL1 (human) |
![]() |
![]() |
3664 | [125I]Fractalkine | |||||
[125I]CXCL13 (mouse) |
![]() |
![]() |
8631 | ||||||
Cy3B-NMU-8 |
![]() |
3863 | |||||||
cyclic INSL3 B-chain analogue 6 | 8333 | ||||||||
cyclo apelin-12 (1-12) | 6313 | C1 | |||||||
cyclo apelin-12 (7-12) | 6311 | C4 | |||||||
cyclo(7-12) Des-AA1,2,5-[Glu7,D-Trp8,IAmp9,m-I-Tyr11,hhLys12]SRIF | 2025 | ||||||||
cyclohexylgriselimycin | 13756 | cyclohexyl-griselimycin | |||||||
Cyclolinopeptide 1-Mso,3-Met-CL6 | 12467 | ||||||||
cyclorelix | 1191 | D-23620 | |||||||
cyclosporin A |
![]() |
![]() |
1024 | ciclosporin, cyclosporine, cyclosporine A, Ikervis® (opthalmic solution), Neoral®, Sandimmun®, Verkazia® (opthalmic solution) | |||||
cyclosporin H | 1025 | ||||||||
cyclotide kalata B1 | 13238 | ||||||||
cyclourea apelin-12 (1-7) | 6312 | C3 | |||||||
[Cy5-Lys19]NPS |
![]() |
9166 | Cy5-hNPS | ||||||
[Cys(ACM)2,7]CGRP | 698 | [Cys(ACM)2,7]-calcitonin gene-related peptide, Cys(Acm)2,7-h-αCGRP | |||||||
[Cys(Et)2,7]α-CGRP (human) | 693 | [cys(Et)2,7]α-calcitonin gene-related peptide (human) | |||||||
D | Back to top | ||||||||
D-23487 | 1180 | D 23487 | |||||||
D-24710 | 1181 | D 24710 | |||||||
ρ-Da1a | 6663 | toxin AdTx1 | |||||||
DADLE | 1607 | [D-Ala2, D-Leu5]-enkephalin, DADL, leucine enkephalin-2-alanine | |||||||
[D-Ala7]-angiotensin(1-7) | 6081 | A-779, A779 | |||||||
(D-Ala11]bombesin | 6179 | ||||||||
[D-Ala2]deltorphin I | 3838 | ||||||||
[3H][D-Ala2]deltorphin I |
![]() |
![]() |
9065 | ||||||
[D-Ala2]deltorphin II | 4060 | ||||||||
[D-Ala2,F5,Phe4]dynorphin-(1-13)-NH2 | 1657 | [D-Ala2,F5,Phe4]-dynorphin 1-13-NH2 | |||||||
[D-Ala2,F5,Phe4]dynorphin-(1-17)-NH2 | 1658 | [D-Ala2,F5,Phe4]-dynorphin 1-17-NH2 | |||||||
D-Ala-Lys-AMCA |
![]() |
5421 | (D)-Ala-(L)-Lys-Nε-AMCA, D-Ala-Lys-N(epsilon)-7-amino-4-methylcoumarin-3-acetic acid | ||||||
DAMGO | 1647 | 2-Ala-4-mephe-5-gly-enkephalin, DAGO, glyol | |||||||
[3H]DAMGO |
![]() |
![]() |
3815 | [3H]-DAMGO, [tyrosyl 3,5-3H]DAMGO | |||||
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P | 1102 | ||||||||
[D-Arg1,D-Trp7,9,Leu11]substance P | 6184 | ||||||||
davalintide | 10684 | DACRA | |||||||
dAVP | 2181 | [deamino-Cys1]AVP, [deamino1]AVP, deamino-vasopressin | |||||||
DAVP | 2170 | [D-Arg8]vasopressin, [D-Arg8]VP | |||||||
dazodalibep |
![]() |
13453 | MEDI-4920, MEDI4920, VIB 4920, VIB-4920, VIB4920 | ||||||
[D-Bpa5,Ile13]motilin (human) | 1450 | ||||||||
DC 23-60 | 2043 | ||||||||
d[Cha4]AVP | 2187 | [1-deamino-4-cyclohexylalanine]AVP, [deamino-Cys1,Cha4]AVP | |||||||
[3H]d[Cha4]AVP |
![]() |
![]() |
2227 | [3H][1-deamino-4-cyclohexylalanine]AVP, [3H][deamino-Cys1,Cha4]AVP | |||||
d[Cha4,Dab8]VP | 2186 | [deamino-Cys1,Cha4,Dab8]vasopressin | |||||||
d[Cha4]LVP | 2188 | [1-deamino-4-cyclohexylalanine]LVP, [deamino-Cys1,Cha4,Lys8]vasopressin | |||||||
d(CH2)5[D-Ile2,Ile4,Ala-NH2]AVP | 2215 | β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Ala-NH2]AVP | |||||||
d(CH2)5[D-Ile2,Ile4,Ala-NH29]AVP | 2214 | β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Ala-NH29]AVP, Pmp[D-Ile2,Ile4,Ala-NH2]AVP | |||||||
d(CH2)5[D-Ile2,Ile4]AVP | 2236 | β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4]AVP, d(CH2)5[D-Ile2,Ile4]VP | |||||||
d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP | 2235 | β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Tyr-NH29]AVP | |||||||
[125I]d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP |
![]() |
![]() |
2230 | [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Tyr-NH29]AVP | |||||
d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP | 2237 | β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Val4,Tyr-NH29]AVP | |||||||
[125I]d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP |
![]() |
![]() |
2231 | [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Val4,Tyr-NH29]AVP | |||||
[125I]d(CH2)5[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP |
![]() |
![]() |
2232 | β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP | |||||
d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP | 2216 | β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Val4,Tyr-NH29]AVP | |||||||
[125I]d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP |
![]() |
![]() |
2233 | [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Val4,Tyr-NH29]AVP | |||||
d(CH2)5[Tyr(Et)2,Val4,des-Gly9]AVP | 2217 | dGTyr(Et)VAVP, Mcp-tva-argipressin, SK&F 101926, SK&F 10196 | |||||||
d(CH2)5[Tyr(Me)2,Arg8]VP | 3867 | ||||||||
d(CH2)5[Tyr(Me)2]AVP | 2223 | CGP-25838, d(CH2)5Tyr(Me)AVP, d(CH2)5[O-methyl-Tyr2]AVP, Pmp[Tyr(Me)2]AVP, SKF-100273, SKF100273 | |||||||
[3H]d(CH2)5[Tyr(Me)2]AVP |
![]() |
![]() |
3813 | [3H]-d(CH2)5[Tyr(Me)2,Arg8]AVP | |||||
[125I]d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT |
![]() |
![]() |
3778 | [125I]-d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT | |||||
d(CH2)5[Tyr(Me)2,Thr4]OVT | 2222 | d(CH2)5[O-Me-Tyr2,Thr4,Orn8]vasotocin, d(CH2)5[O-Me-Tyr2,Thr4]ornithine vasotocin, d(CH2)5[O-Me-Tyr2-The4-Orn8]vasotocin | |||||||
d(CH2)5[Tyr(Me)2,Thr4,Phe(3I,4N3)-NH29]OVT | 2219 | d(CH2)5[Tyr(Me)2,Thr4,Orn8,Phe(3I,4N3)-NH29]vasotocin, I-ZOTA | |||||||
d(CH2)5[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT |
![]() |
![]() |
2218 | β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT, [125I]ZOTA, d(CH2)5[Tyr(Me)2,Thr4,Orn8,Phe(3125I,4N3)-NH29]vasotocin | |||||
d(CH2)5[Tyr(Me)2,Thr4,Tyr(3125I)-NH29]OVT |
![]() |
![]() |
2220 | [125I]D-(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]ornithine vasotocin, [125I]OTA | |||||
d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]OVT | 2221 | β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4,Tyr-NH29]OVT, d(CH2)5[O-Me-Tyr2-Thr4-Orn8-Tyr9-NH2]vasotocin, Pmp[Tyr(Me)2,Thr4,Tyr-NH29]ornithine vasotocin | |||||||
[D-Cys(tBu)5]NPS | 5810 | ||||||||
[3H]d[D-Arg8]VP |
![]() |
![]() |
5403 | [3H]-d[D-Arg8]VP, [3H][D-Arg8]vasopressin, [3H]DAVP | |||||
[3H]dDAVP |
![]() |
![]() |
2228 | [3H]deamino arginine vasopressin, [3H]desmopressin | |||||
d[D-Pal2]AVP | 2184 | d[D-3-Pal2]AVP, Schwartz compound | |||||||
d[D-Phe2]AVP | 2185 | [deamino-Cys1,D-Phe2]AVP | |||||||
degarelix |
![]() |
5585 | FE200486, Firmagon® | ||||||
delcasertib | 7840 | BMS-875944, CS-9803, KAI-9803 | |||||||
deltorphin II | 1615 | (Ala(2))deltorphin II, (Ala(2),glu(4))deltorphin, Delt II, Delt-II | |||||||
[3H]deltorphin II |
![]() |
![]() |
3816 | [3H]-deltorphin II | |||||
demotate 2 | 5636 | N(4) (0-1),Asp0,Tyr3-octreotate | |||||||
Dendroaspis natriuretic peptide | 9070 | DNP | |||||||
α-dendrotoxin | 2563 | α-DTX | |||||||
dendrotoxin-I | 2544 | dendrotoxin, dendrotoxin I, venom basic protease inhibitor 1 | |||||||
dendrotoxin-k | 7738 | DTX-K, Kunitz-type serine protease inhibitor homolog dendrotoxin K, venom basic protease inhibitor K | |||||||
denileukin diftitox |
![]() |
![]() |
7044 | DAB389 IL2, denileukin diftitox-cxdl, LY 335348, Lymphir®, Ontak® | |||||
Des-AA1,2,5,12,13-[D-Trp8]SRIF | 2009 | ||||||||
Des-AA5-[D-Trp8]SRIF | 2012 | ||||||||
Des-AA1,5-[Tyr2,D-Trp8,IAmp9]SRIF | 2011 | CH-288 | |||||||
(des 1-8) A-chain INSL3 analogue | 3754 | ||||||||
Des-Ala1,2,5-[D-Trp8,IAmp9]SRIF | 2010 | ||||||||
[des-Arg10]icatibant | 663 | [D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]-des-Arg9]bradykinin, [des-Arg10]HOE140 | |||||||
[des-Arg11]T-kinin | 645 | [Ile,Ser,des-Arg9]bradykinin | |||||||
[des-Gly10,D-Ala6]GnRH N-ethylamide | 1174 | ||||||||
[125I][des-Gly10,D-Ala6]GnRH N-ethylamide |
![]() |
![]() |
1166 | ||||||
desGlyNH2-d(CH2)5[Tyr(Me)2,Thr4,Orn8]OT | 3870 | ||||||||
[3H]desGly-NH2[D-Ile2,Ile4]VP |
![]() |
![]() |
3817 | [3H]-desGly-NH2[D-Ile2,Ile4]AVP | |||||
des-His1-[Glu9]glucagon-NH2 | 1150 | des-His(1)-[Glu9]-glucagon-NH2 | |||||||
des-His1-[Leu4-Glu9]glucagon-NH2 | 1151 | des-His(1)-[Leu4-Glu9]-glucagon-NH2 | |||||||
desirudin |
![]() |
6458 | CGP 39393, CGP-39393, CGP39393 | ||||||
deslorelin | 9343 | ||||||||
desmopressin |
![]() |
2182 | 1-deamino,D-AVP, [deamino-Cys1,D-Arg8]vasopressin, dDAVP, Noctiva® | ||||||
[des-Phe9,des-Arg10]kallidin | 647 | [Lys,des-Phe8,Arg9]bradykinin | |||||||
[des-Pro8,des-Phe9,des-Arg10]kallidin | 648 | [des-Pro7,Phe8,Arg9]Lys-bradykinin | |||||||
desulfated cholecystokinin-8 | 3725 | CCK-8 (desulphated), des-CCK-8, desulfated sincalide | |||||||
DFGYVAE | 3023 | ||||||||
difelikefalin |
![]() |
![]() |
9044 | CR845, D-Phe-D-Phe-D-Leu-D-Lys-[γ-(4-N-piperidinyl)amino carboxylic acid], FE-202845, Kapruvia®, Korsuva®, SEQ ID NO: 2 | |||||
DkTx | 4178 | Double-knot toxin | |||||||
d[Leu4]AVP | 2190 | [deamino-Cys1,Leu4,Arg8]vasopressin | |||||||
d[Leu4,Dap8]VP | 2189 | [deamino-Cys1,Leu4,Dap8]vasopressin | |||||||
d[Leu4]LVP | 2191 | [deamino-Cys1,Leu4,Lys8]vasopressin, d[Leu4,Lys8]VP, d[Leu4]lysine vasopressin | |||||||
D-Lys0-[des-Arg10]kallidin | 636 | D-[Lys,Lys,des-Arg9]bradykinin | |||||||
[D-Lys1,des-Arg10]kallidin | 640 | D-[Lys,des-Arg9]bradykinin | |||||||
[D-Lys3]-GHRP-6 | 11814 | [D-Lys] GHRP-6 | |||||||
[D-Lys6]GnRH-II | 5581 | ||||||||
1DMe | 1477 | [D-Tyr1,(NMe)Phe3]neuropeptide FF, [D.Tyr1,(N.Me)Phe3]NPFF | |||||||
[125I]1DMe |
![]() |
![]() |
1483 | ||||||
dNal-cyc(Cys-Tyr-dTrp-Orn-Val)-Nal-NH2 | 3871 | ||||||||
D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2 | 635 | analogue #30 [PMID: 19463875] | |||||||
D-Nal,Cys,Tyr,D-Trp,Orn,Val,Cys,Nal-NH2 | 6172 | ||||||||
dNPA | 1489 | ||||||||
dolcanatide | 10011 | ||||||||
DOTA-BASS | 5645 | DOTA-BASS analog 2 | |||||||
[111In]DOTA-BOC-ATE |
![]() |
![]() |
2063 | [111In-DOTA]-BOC-ATE, [InIII-DOTA]-BOC-ATE, [InIII-DOTA]-BOC-ATE | |||||
[111In]DOTA-dLVT |
![]() |
![]() |
3756 | [111In]-DOTA-dLVT, [111In]-DOTA-Lys8-deamino-vasotocin, [111indium]DOTA-dLVT | |||||
DOTA/Eu relaxin-3 |
![]() |
11912 | |||||||
DOTA-JR11 | 10113 | ||||||||
[111In,90Y]DOTA-LAN |
![]() |
![]() |
2056 | DOTA-conjugated peptide, YIII-DOTA-LAN | |||||
[111In]DOTA-NOC |
![]() |
![]() |
2045 | [111In-DOTA]-NOC, [InIII-DOTA]-NOC, [InIII-DOTA]-NOC | |||||
[111In,90Y]DOTA-NOC |
![]() |
![]() |
2057 | 90Y-DOTA-NOC, [90Y-DOTA]-1-Nal3-octreotide, YIII-DOTA-NOC | |||||
[111In]DOTA-NOC-ATE |
![]() |
![]() |
2064 | [111In-DOTA]-NOC-ATE, [InIII-DOTA]-NOC-ATE, [InIII-DOTA]-NOC-ATE | |||||
[111In,90Y]DOTA-OC |
![]() |
![]() |
2058 | [3Y]DOTA-OC, [3Y]DOTA-octreotide, YIII-DOTA-OC | |||||
[111In,90Y]DOTA-TOC |
![]() |
![]() |
2059 | YIII-DOTA-TOC, YIII-DOTA-Tyr3-octreotide, YIII-DOTA-TOC | |||||
DPDPE | 1608 | 2,5-pen-enkephalin, D-penicillamine (2,5)-enkephalin, DPLPE | |||||||
[3H]DPDPE |
![]() |
![]() |
3819 | [3H]-[d-Pen2,d-Pen5]-Enkephalin, [3H]-DPDPE | |||||
d[Pen1,Tyr(Me)2]AVP | 2225 | 1-deaminopenicillamine-2-(O-methyl-tyr)-argipressin, dPTyr(Me)AVP | |||||||
[D-Phe6,β-Ala11,Phe13,Nle14]bombesin-(6-14) | 632 | [D-Phe6,β-Ala11,Phe13,Nle14]bombesin(6-14) | |||||||
[D-Phe12]bombesin | 6181 | ||||||||
[D-Phe6]bombesin(6-13)methyl ester | 6180 | ||||||||
[D-Phe6]bombesin(6-13)propylamide | 6182 | ||||||||
D-Phe-CRF-(12-41) | 3865 | D-Phe-corticotropin-releasing factor(12-41), D-Phe-CRF(12-41), D-Phe12,Nle21,38,αMeLeu37-CRF | |||||||
[D-Phe6, Leu13, Cpa14,ψ13-14]bombesin-(6-14) | 3840 | [D-Phe6,Cpa14,ψ13-14]bombesin6-14, [D-Phe6,Leu13,Cpa14,ψ13-14]bombesin-(6-14), analogue #7 [PMID: 19463875] | |||||||
[D-Phe6, Stat13, Leu14}Bn(6-14) | 12494 | RM-2, RM2 | |||||||
[D-Pro4,D-Trp7,9,10]substance P (4-11) | 6185 | ||||||||
drotrecogin alfa |
![]() |
6788 | drotrecogin alfa (activated), HSDB 7366, Xigris® | ||||||
DSLET | 1609 | [D-Ser2, Leu5, Thr6]-enkephalin, Dislet, DSTLE | |||||||
D1SP | 13660 | ||||||||
DSTBULET | 3873 | ||||||||
(D-Thr6, D-Trp8,9)galanin(1-15)ol | 6133 | (D-THR6,D-TRP8,9,L-ALANINOL15)-GALANIN (1-15) | |||||||
[D-Tpi6, Leu13 ψ(CH2NH)-Leu14]bombesin-(6-14) | 6183 | (D-Tpi6, Leu13ψ(CH2-NH)-Leu14)bombesin (6-14), D-Tpi-Gln-Trp-Ala-Val-Gly-His-Leu-Y(CH2-NH)-Leu-NH2 trifluoroacetate salt, RC-3095 | |||||||
[D-Trp2]galanin-(1-29) | 3866 | [D-Trp2]galanin(1-29) | |||||||
[D-Trp8]γ-MSH | 1334 | D-Trp8 γ-melanocyte stimulating hormone, D-Trp8 γ-MSH, D-Trp8-y-MSH | |||||||
[D-Trp11]neurotensin | 1584 | D-Trp11-neurotensin | |||||||
[D-Trp32]NPY | 1544 | [D-Trp32] neuropeptide Y, [D-Trp32]-NPY | |||||||
[D-Trp12]PTH-(7-34) (bovine) | 1820 | [D-Trp12]-PTH 7-34 (bovine) | |||||||
[D-Trp12,Tyr34]PTH-(7-34) (bovine) | 1819 | [D-Trp12,Tyr34]-PTH 7-34 (bovine) | |||||||
[125I]α-DTX |
![]() |
![]() |
2564 | ||||||
[D-Tyr6,β-Ala11,N-Me-Ala13,Nle14]bombesin-(6-14) | 11434 | ||||||||
[125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin-(6-14) |
![]() |
![]() |
631 | [125I]-[Tyr6,βAla11,Phe13,Nle14] bombasin-6-14, [125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin(6-14) | |||||
[D-Tyr6,Apa-4Cl11,Phe13,Nle14]bombesin-(6-14) | 3946 | [D-Tyr6,Apa-4Cl11,Phe13,Nle14]bombesin6-14 | |||||||
[D-Tyr6,(R)-APA11,Phe13,Nle14]bombesin-(6-14) | 633 | [D-Phe6,(R)-APA11,Phe13,Nle14]bombesin(6-14) | |||||||
[125I][D-Tyr6]bombesin-(6-13)-methyl ester |
![]() |
![]() |
628 | ||||||
[D-Tyr8]CYN 154806 | 2028 | cyanamid 154806, CYN 154806, D-Tyr8-CYN 154806 | |||||||
[125I]DTyr-Gly-[(Nle28,31)CCK-26-33 |
![]() |
![]() |
6666 | ||||||
dulaglutide |
![]() |
7638 | GLP-1Fc, LY2189265, Trulicity® | ||||||
duramycin | 841 | ||||||||
d[Val4,DArg8]VP | 3869 | ||||||||
[D-Val5]NPS | 5811 | ||||||||
dVDAVP | 2183 | 1-deamino-4-val-8-arg-vasopressin, [deamino-Cys1,Val4,D-Arg8]AVP, d[Val4]AVP | |||||||
DW13.3 | 2527 | ω-filistatoxin-Kh1a, ω-FLTX-Kh1a, DW13.3 toxin | |||||||
DX600 | 11602 | DX-600 | |||||||
[dY]1KP-10 | 4015 | ||||||||
dynorphin-(1-11) | 1618 | dynorphin 1-11, dynorphin A (1-11) | |||||||
dynorphin-(1-17)-NH2 | 1661 | dynorphin 1-17-NH2 | |||||||
E | Back to top | ||||||||
E2078 | 1648 | E 2078, E-2078, N-Me-tyr(1)-N-Me-arg(7)-N-Et-leunh2(8)-dynorphin (1-8), N-methyl-Tyr1,N-methyl-Arg7,D-leu8-dynorphin-A(1-8) | |||||||
E7 | 3915 | (Trp63-Trp64)-C3a-(63-77), C3a receptor superagonist, EP141 | |||||||
EC 5-21 | 2044 | ||||||||
ecallantide |
![]() |
![]() |
6955 | DX-88, FOV2302, Kalbitor® | |||||
echistatin | 6594 | ||||||||
E. coli heat-stable enterotoxin (STa) | 4854 | ||||||||
edotreotide |
![]() |
5638 | DOTA-Tyr3-octreotide, DOTA0-Phe1-Tyr3-octreotide, Ga-DOTA-TOC, Ga-DOTATOC, SMT487, SomaKit TOC® | ||||||
efanesoctocog alfa |
![]() |
13086 | ALTUVIIIO®, Altuvoct®, BIVV-001, BIVV001, Fc-VWF-XTEN | ||||||
efineptakin alfa |
![]() |
11097 | GX-I7, Hyleukin-7, Il-7 hybrid Fc, NT-I7, rhIL-7-hyFc, TJ-107 | ||||||
eflapegrastim |
![]() |
12180 | eflapegrastim-xnst, HM-10460A, HM10460A, rolontis, Rolvedon®, SPI-2012, SPI2012 | ||||||
EFWSLAAPQRF-NH2 | 1478 | EFW-NPSF | |||||||
efzofitimod |
![]() |
13199 | ATYR-1923, ATYR1923, KRP-R120 | ||||||
EG3287 | 11290 | VEGFA(138-165) | |||||||
[125I]EGF (human) |
![]() |
![]() |
4848 | [125I]-epidermal growth factor | |||||
EISAI-1 | 1566 | ||||||||
EISAI-2 | 1567 | ||||||||
EK-1 | 11500 | ||||||||
EK-1-C4 | 11501 | EK1C4 | |||||||
eledoisin | 2086 | ELD 950, ELD-950, eledone peptide | |||||||
elosulfase alfa |
![]() |
7392 | BMN 110, rhGALNS, Vimizim® | ||||||
eneboparatide | 13815 | AZP-3601, AZP3601, LA-PTH | |||||||
ensovibep | 11470 | MP-0420, MP0420 | |||||||
ErgTx-1 | 2612 | CnErg1, CnErgTx1, ergtoxin, ergtoxin-like protein 1, ErgTx, ErgTx1, potassium channel toxin gamma-KTx 1.1 | |||||||
etanercept |
![]() |
![]() |
6789 | Enbrel®, Rhu Tnfr:Fc, TNFR-Fc, TNR 001 | |||||
etelcalcetide |
![]() |
8375 | AMG 416, AMG-416, KAI-4169, Parsabiv®, velcalcetide | ||||||
[125I]ET-2 (human) |
![]() |
![]() |
992 | [125I]endothelin-2 | |||||
[125I]ET-1 (human, mouse, rat) |
![]() |
![]() |
991 | [125I]endothelin-1 | |||||
[18F]ET-1 (human, mouse, rat) |
![]() |
![]() |
994 | [18F]endothelin-1 | |||||
Eu-DTPA-hC3a |
![]() |
11286 | |||||||
Eu-DTPA-[Ser27, Nle70]hC5a |
![]() |
12516 | |||||||
europium-labelled INSL3 |
![]() |
3875 | |||||||
europium-labelled INSL5 |
![]() |
4375 | |||||||
europium-labelled mouse INSL5 |
![]() |
6522 | |||||||
europium-labelled R3(B1-22R) |
![]() |
8342 | Eu R3(B1-22R) | ||||||
europium-labelled relaxin |
![]() |
3874 | europium-labelled H2 relaxin | ||||||
europium-labelled relaxin-3-B/INSL5 A chimera |
![]() |
4374 | Eu-R3/I5, europium-labelled H3-B/INSL5 A chimera | ||||||
evorpacept | 11592 | ALX-148, ALX148 | |||||||
examorelin | 1100 | EP-23905, hexarelin, MF-6003 | |||||||
exendin-3 | 3730 | ||||||||
exendin-4 |
![]() |
1135 | AC 2993, AC002993, AC2993A, Bydureon®, Byetta® | ||||||
exendin-(9-39) | 1138 | exendin (9-39), exendin 3 [Heloderma horridum horridum (Mexican beaded lizard)] (9-39)-peptide 39-amide (from INN record), exendin(9-39), exendin-(9-39) amide, Exendin-3-(9-39) amide | |||||||
[125I]exendin-(9-39) |
![]() |
![]() |
1137 | [125I]exendin (9-39) | |||||
[125I]EYF |
![]() |
![]() |
1488 | [125I]-EYF | |||||
[3H]EYF |
![]() |
![]() |
4021 | [3H]-EYF | |||||
F | Back to top | ||||||||
F180 | 2171 | [2-hydroxy-3-mercaptopropionic acid-1, Phe-2, Hgn-4. Dab(Abu)-8]OT, F 180 | |||||||
fertirelin | 9341 | ||||||||
[F/G]N/OFQ-(1-13)-NH2 | 1690 | [F/G]N/OFQ(1-13)NH2, [F/G]nociceptin(1-13)NH2, [F/G]nociceptin/orphanin FQ(1-13)NH2, [F/G]orphanin FQ(1-13)NH2 | |||||||
filgrastim |
![]() |
![]() |
6968 | Filcad®, Imumax ®, R-METHUG-CSF | |||||
FK 224 | 2103 | FK-224, FK224 | |||||||
FLPLAR | 5761 | ||||||||
FLTChaAR | 5777 | ||||||||
F2L-[125I]Tyr |
![]() |
![]() |
1045 | ||||||
Flu-CCL3 |
![]() |
760 | Flu-LD78α, Flu-MIP-1α, fluorescent macrophage inflammatory protein-1α | ||||||
4-fluorobenzoyl-FGLRW-NH2 | 4014 | ||||||||
fMet-Ile-Phe-Leu | 1021 | fMet-Ile-Phe-Leu [S. aureus] | |||||||
fMet-Ile-Val-Ile-Leu | 5842 | fMet-Ile-Val-Ile-Leu [L. monocytogenes] | |||||||
fMet-Ile-Val-Thr-Leu-Phe | 5841 | fMet-Ile-Val-Thr-Leu-Phe [L. monocytogenes] | |||||||
fMet-Leu-Phe | 1022 | fMLP, fMetLeuPhe, fMLF, formyl-Met-Leu-Phe | |||||||
[3H]fMet-Leu-Phe |
![]() |
![]() |
1018 | [3H]fMet-Leu-Phe, [3H]fMLP | |||||
fMet-Leu-Phe-Glu | 5840 | fMet-Leu-Phe-Glu [E. coli] | |||||||
fMet-Leu-Phe-Ile-Ile-Lys-FITC |
![]() |
5843 | |||||||
fMet-Met-Trp-Leu-Leu | 5837 | ||||||||
fMet-Met-Tyr-Ala-Leu-Phe | 1023 | fMet-Met-Tyr-Ala-Leu-Phe [Mitochondria] | |||||||
FMRFamide | 4195 | Phe-Met-Arg-Phe-amide | |||||||
FP-1039 | 11581 | FGFR1:Fc, FP1039, GSK-3052230, GSK3052230, HGS1036 | |||||||
F peptide | 6247 | ||||||||
(3,5)-[19F]2-Phe-ψ-Ala |
![]() |
![]() |
11370 | (3,5)-difluoro Phe-ψ-Ala | |||||
FPRL1-inhibitor protein | 6264 | FLIPr | |||||||
FPYVAE peptide [PMID: 20494585] | 3024 | ||||||||
FSH deglycosylated α/β | 1158 | ||||||||
[125I]FSH (human) |
![]() |
![]() |
3780 | [125I]-follicle-stimulating hormone, [125I]-FSH | |||||
FSH α subunit-deglycosylated form | 5536 | ||||||||
FSH β subunit-deglycosylated form | 5537 | ||||||||
furin inhibitor peptide | 8668 | ||||||||
2-furoyl-LIGRL[N-(Alexa Fluor 594)-O]-NH2 |
![]() |
4050 | Alexa Fluor 594-2fLI | ||||||
[3H]2-furoyl-LIGRL-NH2 |
![]() |
![]() |
6660 | ||||||
2-furoyl-LIGRL[N[3H]propionyl]-O-NH2 |
![]() |
![]() |
4049 | [3H]propionyl-2fLI | |||||
2-furoyl-LIGRLO-amide | 3851 | ||||||||
Fz7-21 | 10324 | ||||||||
G | Back to top | ||||||||
G4120 | 6588 | cyclic Arg-Gly-Asp-containing pentapeptide, cyclic RGD, G 4120, G-4120, L-cysteine, N-(mercaptoacetyl)-D-tyrosyl-L-arginylglycyl-L-alpha- aspartyl-cyclic(1-->5)-sulfide, 5-oxide | |||||||
Ga-DOTA-NOC | 5639 | ||||||||
[Ga-DOTA,Tyr3,Thr8]octreotide | 5632 | Ga-DOTA-octreotate, Ga-DOTA-TATE, Ga-DOTATATE | |||||||
Ga-KE88 | 5640 | ||||||||
galanin {Sp: Pig} | 6129 | ||||||||
galanin(1-10) | 6140 | ||||||||
galanin(1-11) | 6084 | AR-M1717 | |||||||
galanin-(1-11) | 5356 | galanin (1-11) | |||||||
galanin(1-12) | 6141 | ||||||||
galanin(1-15) | 6086 | ||||||||
galanin(2-11) | 5357 | AR-M1896 | |||||||
galanin(1-13)amide | 6085 | ||||||||
galanin(D-Trp2) (pig) | 6095 | ||||||||
galanin(1-19) (human) | 6088 | ||||||||
galanin(1-20) (human) | 6137 | ||||||||
galanin(2-30) (human) | 6090 | ||||||||
galanin(3-30) (human) | 6138 | ||||||||
galanin-like peptide {Sp: Pig} | 6120 | ||||||||
galanin(10-29) (pig) | 6094 | ||||||||
galanin(2-29) (pig) | 6130 | ||||||||
galanin(3-29) (pig) | 6091 | ||||||||
galanin(5-29) (pig) | 5359 | galanin (5-29) (pig) | |||||||
galanin(7-29) (pig) | 6083 | ||||||||
galanin(10-29) (rat/mouse) | 6093 | ||||||||
galanin(1-19) (rat/mouse) | 6139 | ||||||||
galanin(2-29) (rat/mouse) | 3876 | galanin (2-29) | |||||||
galanin(3-29) (rat/mouse) | 6092 | ||||||||
galanin(5-29) (rat/mouse) | 6134 | ||||||||
galanin(9-25) (rat/mouse) | 6136 | ||||||||
galanin(9-29) (rat/mouse) | 6135 | ||||||||
galanin(1-16) (rat/mouse/pig) | 6087 | ||||||||
Gal-B2 | 6105 | NAX 5055 | |||||||
Gal-B5 | 6107 | ||||||||
Gal-B2-C10 | 6112 | ||||||||
Gal-B2-C12 | 6113 | ||||||||
Gal-B2-C14 | 6114 | ||||||||
Gal-B2-C18 | 6115 | ||||||||
Gal-B2-C8 | 6111 | ||||||||
Gal-B2-dPEG24 | 6106 | ||||||||
Gal-B2-MPEG4 | 6116 | ||||||||
Gal-(K)4 | 6110 | ||||||||
galparan | 6096 | ||||||||
GALP(1-32) (human) | 6121 | ||||||||
GALP(3-32) (human) | 6122 | ||||||||
Gal-R2-dPEG24 | 6108 | ||||||||
ganirelix |
![]() |
3877 | D 24598, D-24598, Orgalutran®, RS 26306, RS-26306 | ||||||
Ga-NODAGA-LM3 | 5643 | ||||||||
[125I]gastrin |
![]() |
![]() |
3781 | [125I]-gastrin | |||||
[3H]gastrin |
![]() |
![]() |
3821 | [3H]-gastrin | |||||
gastrin-releasing peptide {Sp: Pig} | 3581 | ||||||||
gastrin releasing peptide(14-27) (human) | 6175 | GRP(14-27) | |||||||
GaTx1 | 4198 | Toxin GaTx1 | |||||||
GaTx2 | 4199 | ||||||||
[G(B24)S]R3/I5 | 11909 | ||||||||
GC-373 | 11635 | GC373, N-benzyloxycarbonyl-L-leucyl-3-(2-oxopyrrolidin-3-yl)-L-alaninal | |||||||
[125I]GDNF (rat) |
![]() |
![]() |
4851 | [125I]-GDNF (rat) | |||||
GE-137 |
![]() |
8585 | |||||||
gG-2p20 | 5839 | ||||||||
[125I]GHRH (human) |
![]() |
![]() |
3783 | [125I]-GHRH, [125I]-growth hormone releasing hormone, [125I]-Tyr10-hGHRH(1-44)NH2, [125I]GHRH(1-44)NH2 | |||||
GHRH-(1-29)-NH2 (human) | 1103 | GHRH (1-29)NH2 (human), human growth hormone releasing hormone (1-29)NH2 | |||||||
GHRH-(1-29)-NH2 (rat) | 1104 | GHRH(1-29)NH2 (rat), rat growth hormone releasing hormone (1-29)NH2 | |||||||
GHRH-(1-29)-OH (human) | 1105 | GHRH(1-29)OH (human), human growth hormone releasing hormone (1-29)OH | |||||||
GHRP-6 | 1093 | GH-releasing hexapeptide 6, growth hormone releasing hexapeptide, growth hormone releasing peptide-6, Skf 110679 | |||||||
GIP-(10-30) | 1128 | gastric inhibitory polypeptide10-30, GIP10-30 | |||||||
GIP-(7-30) | 1130 | gastric inhibitory polypeptide7-30, GIP7-30 | |||||||
GIP-(6-30)-amide | 1129 | gastric inhibitory polypeptide6-30 amide, GIP6-30 amide | |||||||
[125I]GIP (human) |
![]() |
![]() |
1131 | [125I]-GIP, [125I]gastric inhibitory polypeptide | |||||
glepaglutide | 10885 | ZP-1848, ZP1848 | |||||||
[Gln8]GnRH | 1169 | chicken GnRH | |||||||
GLP-1-(9-36) | 6524 | ||||||||
[125I]GLP-1-(7-36)-amide |
![]() |
![]() |
1134 | [125I]GLP-1, [125I]GLP-1(7-36)amide, [125I]glucagon-like peptide 1 (7-36) | |||||
GLP-2 analogue 10 |
![]() |
9896 | |||||||
GLPDGG peptide [PMID: 20494585] | 2980 | ||||||||
[125I]GLP-1-(7-37) (human) |
![]() |
![]() |
3784 | [125I]-GLP-1(7-37), [125I]-glucagon-like peptide-1(7-37), [125I]GLP-1(7-37) | |||||
[125I][Glp65Nle75,Tyr77]apelin-13 |
![]() |
![]() |
3761 | [125I](Pyr1)[Nle75,Tyr77]-apelin-13, [125I]-[Glp65Nle75,Tyr77]apelin-13, [125I][Glu65,Nle75,Tyr77]apelin-13 | |||||
GLP-2-(1-29) (rat) | 1139 | GLP-2 (1-29) (rat), rat glucagon-like peptide 2 (1-29) | |||||||
glucagon-(1-21) | 1146 | glucagon 1-21 | |||||||
glucagon-(1-6) | 1147 | glucagon 1-6 | |||||||
[125I]glucagon (human, mouse, rat) |
![]() |
![]() |
3785 | [125I]-glucagon | |||||
glucarpidase |
![]() |
7450 | Voraxaze® | ||||||
glutathione |
![]() |
6737 | GSH | ||||||
glycyl-sarcosine | 9505 | Gly-Sar, glycylsarcosine | |||||||
GM-109 | 1466 | GM 109, GM109 | |||||||
GMAP(1-41) {Sp: Pig} | 6131 | galanin message associated peptide fragment 1-41 amide, porcine, preprogalanin 65-105 amide | |||||||
GMAP(44-59) {Sp: Pig} | 6132 | galanin message associated peptide fragment 44-59 amide, preprogalanin 108-123 amide | |||||||
[125I]GnRH I (human, mouse, rat) |
![]() |
![]() |
3786 | [125I]-GnRH I, [125I]-gonadotropin-releasing hormone I | |||||
[125I]GnRH II (human) |
![]() |
![]() |
3787 | [125I]-GnRH II, [125I]-gonadotropin-releasing hormone II | |||||
GnRH III | 3878 | gonadoliberin III, gonadoliberin-3, Gonadotropin-releasing hormone III, lamprey GnRH III, Luliberin III | |||||||
goserelin |
![]() |
3879 | decapeptide I, ICI 118630, Zoladex® | ||||||
GR100679 | 3880 | GR 100679, GR-100679 | |||||||
GR138676 | 2128 | GR 138676, GR-138676 | |||||||
GR231118 | 1529 | GR 231118, GR-231118, GW 1229, GW-1229, GW1229 | |||||||
GR64349 | 3881 | GR-64349, Lys-Asp-Ser-Phe-Val-Gly-(R-γ-lactam) | |||||||
GR94800 | 3882 | GR 94800, GR-94800 | |||||||
[125I]GR231118 |
![]() |
![]() |
1531 | [125I]1229U91, [125I]GW1229 | |||||
[3H]GR100679 |
![]() |
![]() |
3822 | [3H]-GR100679 | |||||
ω-grammotoxin SIA | 2539 | ω-GrTx SIA, omega-grammotoxin SIA, omega-GsTx SIA, omega-GTX SIA | |||||||
GRASP | 12844 | ||||||||
[125I]GRP (human) |
![]() |
![]() |
3788 | [125I]-gastrin-releasing peptide, [125I]-GRP | |||||
GsMTx-4 | 4206 | M-theraphotoxin-Gr1a, M-TRTX-Gr1a, MTx4, Toxin GsMTx-4 | |||||||
GxTx-1E | 7760 | κ-theraphotoxin-Pg1a, κ-TRTX-Pg1a, guangxitoxin-1E | |||||||
GYPGKF-NH2 | 3883 | ||||||||
GYPGQV-NH2 | 3739 | ||||||||
H | Back to top | ||||||||
H3 Ac-B10-27(13-17 HC) | 11908 | ||||||||
HAS-NMU | 7925 | ||||||||
[3H]haTRAP |
![]() |
![]() |
3823 | [3H]-haTRAP, Ala-p-fluoroPhe-Ala-Arg-cyclohexylAla-homoArg-[3H]Tyr-amide | |||||
HaTx1 | 7762 | κ-theraphotoxin-Gr1a, κ-TRTX-Gr1a, hanatoxin-1 | |||||||
H-c[Cys-Phe-LAgl(NβMe,benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH | 2079 | ||||||||
H-c[Cys-Phe-LAgl(NβMe,benzoyl)-Trp-Lys-Thr-Phe-Cys]-OH | 2080 | ||||||||
H-c[DCys-Phe-LAgl(NβMe,benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH | 2081 | ||||||||
H3-CoA-20 | 7035 | ||||||||
HelaTx1 | 7737 | HL15-1-1, potassium channel toxin kappa-KTx 5.1 | |||||||
α-helical CRF | 923 | α-helical corticotropin, α-helical CRF (9-41), alpha-helical CRF (9-41) | |||||||
helodermin | 2280 | Exendin 2 | |||||||
HER-096 | 13049 | HER096 | |||||||
heteropodatoxin-2 | 2581 | κ-sparatoxin-Hv1b, κ-SPRTX-Hv1b, HpTX2, HpTx2, Toxin KJ6 | |||||||
δ-hexatoxin-Mg1a | 7569 | Delta-HXTX-Mg1a, neurotoxin magi-4 | |||||||
hGLP-2(1-33,M10Y) | 11804 | ||||||||
hGLP-2(3-33,M10Y) | 11805 | ||||||||
hINSL5: A8-21 (T15K) | 12504 | analogue 13 [PMID: 26824523] | |||||||
hINSL5: A8-21 (T9R) | 9324 | ||||||||
Hip-His Leu | 5197 | Hippuryl-His-Leu | |||||||
[His5,Arg19]PTH-(1-34) (human) | 1793 | [His5,Arg19]-PTH 1-34 (human) | |||||||
[His5,D-Tyr6]GnRH | 1170 | ||||||||
[125I][His9]ghrelin (human) |
![]() |
![]() |
1094 | [125I-His9]ghrelin, [125I] His9-ghrelin (human) | |||||
[His5]PTH-(1-34) (human) | 1794 | [His5]-PTH 1-34 (human) | |||||||
histerelin | 9344 | ||||||||
histidyl-leucine | 9485 | His-leu, Histidylleucine, L-histidyl-L-leucine | |||||||
histrelin |
![]() |
3884 | ORF 17070, RWJ 17070, Vantas® | ||||||
[His4, Tyr5, Trp6, His7]TIP39 (human) | 5572 | [His4, Tyr5, Trp6, His7]-hTIP39, [His4, Tyr5, Trp6, His7]-TIP39 (human), HYWH-TIP39 | |||||||
HIV-1 matrix protein p17 | 8495 | ||||||||
HIV-Tat | 773 | Tat1-86 | |||||||
hK2p01 derivative KLK2 inhibitor | 8672 | ||||||||
Hm1a | 9553 | δ-theraphotoxin-Hm1a | |||||||
HmTx1 | 2580 | κ-theraphotoxin-Hm1a, κ-TRTX-Hm1a, Heteroscodratoxin-1 | |||||||
hongotoxin-1 | 2545 | HgTX1, potassium channel toxin α-KTx 2.5 | |||||||
Hp(2-20) | 1046 | ||||||||
HpARI |
![]() |
9685 | H. polygyrus Alarmin Release Inhibitor | ||||||
H. polygyrus TGF-β mimic |
![]() |
9713 | Hp-TGM | ||||||
[125I]Hpp-desArg10HOE140 |
![]() |
![]() |
3791 | [125I]-Hpp-desArg9HOE140 | |||||
[125I]HPP-HOE140 |
![]() |
![]() |
11436 | [125I]-3-4-hydroxyphenyl-propionyl-d-Arg0-[Hyp3,Thi5,d-Tic7,Oic8]bradykinin | |||||
[125I]-HPP-icatibant |
![]() |
![]() |
11158 | [(125)I]-HPP-Hoe 140, [125I]3-4 hydroxyphenyl-propionyl-D-Arg[Hyp3, Thi5, D-Tic7, Oic8]-BK, [125I]3-4 hydroxyphenyl-propionyl-D-Arg[Hyp3, Thi5, D-Tic7, Oic8]-bradykinin, [125I]3-4 hydroxyphenyl-propionyl-icatibant | |||||
HS014 | 1321 | HS 014 | |||||||
HS024 | 1328 | cyclic[AcCys3,Nle4,Arg5,D-Nal7,Cys-NH2(11)]alpha-MSH-(3-11), HS 024 | |||||||
H3 14s18 stapled B-chain | 11910 | ||||||||
HsTX1[R14A] |
![]() |
9582 | KTx 6.3 | ||||||
5-HT-moduline | 137 | PEPTIDE1{L.S.A.L}$$$$ | |||||||
human GIP(1-30)NH2 | 8973 | ||||||||
human GIP(3-30)NH2 | 8971 | ||||||||
human GIP(3-42)NH2 | 8970 | ||||||||
human GIP(5-30)NH2 | 8972 | ||||||||
huwentoxin IV | 7570 | huwentoxin-4, HwTx-IV | |||||||
[Hyp3,Tyr(Me)8]BK | 3841 | [Hyp3,Tyr(Me)8]bradykinin | |||||||
I | Back to top | ||||||||
iberiotoxin |
![]() |
4218 | IbTX | ||||||
i-Boc-Met-Leu-Phe | 1028 | ||||||||
icatibant |
![]() |
![]() |
667 | D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]BK, Firazyr®, HOE 140, HOE140 | |||||
ICI 174,864 | 1636 | ICI-174,864, ICI-174864 | |||||||
γ-iE-DAP | 9504 | γ-D-glutamyl-meso-diaminopimelic acid, Gamma-D-Glu-mDAP, Gamma-d-glutamyl-meso-diaminopimelic acid, iE-DAP | |||||||
IFN-β1a (recombinant human) |
![]() |
8339 | Avonex®, Rebif® | ||||||
IFN-γ1b (human recombinant) |
![]() |
8341 | Actimmune®., IFNγ2a | ||||||
IFN-α2b (recombinant human) |
![]() |
8338 | Intron A®, intronA | ||||||
IFN-β1b (recombinant human) |
![]() |
![]() |
8340 | Betaferon®, Betaseron®, Extavia®, IFNb1b | |||||
IgE heavy chain |
![]() |
9557 | |||||||
[Ile31,Gln34]PP (human) | 1555 | [Ile31,Gln34]-PP (human), human [Ile31,Gln34] pancreatic peptide | |||||||
[Ile5,Glu19]PTHrP-(1-34) (human) | 1796 | ||||||||
[Ile5,Glu19,Val21]PTHrP-(1-34) (human) | 1795 | [Ile5,Glu19,Val21]-PTHrP 1-34 (human) | |||||||
[Ile5]PTHrP-(1-36) | 1825 | [Ile5]-PTHrP 1-36 | |||||||
[Ile5]PTHrP-(1-34) (human) | 1803 | [Ile5]-PTHrP 1-34 (human) | |||||||
[Ile5]PTHrP-(1-36) (human) | 1804 | [Ile5]-PTHrP 1-36 (human) | |||||||
[Ile5,Trp23]PTHrP-(5-36) | 1821 | [Ile5,Trp23]-PTHrP 5-36 | |||||||
[Ile5,Trp23]PTHrP-(1-36) (human) | 1798 | [Ile5,Trp23]-PTHrP 1-36 (human) | |||||||
[Ile5,Trp23]PTHrP-(2-36) (human) | 1799 | [Ile5,Trp23]-PTHrP 2-36 (human) | |||||||
[Ile5,Trp23]PTHrP-(3-36) (human) | 1800 | [Ile5,Trp23]-PTHrP 3-36 (human) | |||||||
[Ile5,Trp23]PTHrP-(4-36) (human) | 1801 | [Ile5,Trp23]-PTHrP 4-36 (human) | |||||||
[Ile5,Trp23]PTHrP-(5-36) (human) | 1824 | [Ile5,Trp23]-PTHrP 5-36 (human) | |||||||
[Ile5,Trp23,Tyr36]PTHrP-(1-36)-NH2 (human) | 1797 | [Ile5,Trp23,Tyr36]-PTHrP 1-36-NH2 (human) | |||||||
[Ile5,Val21]PTHrP-(1-34) (human) | 1802 | [Ile5,Val21]-PTHrP 1-34 (human) | |||||||
inbakicept | 11593 | 15RalphaSu-Fc | |||||||
In-NODAGATOC | 5642 | In-NODAGA-Tyr3-octreotide | |||||||
INSL3 [A(5-26):B(7-27)] | 11914 | ||||||||
INSL5 amide (human) | 8350 | ||||||||
INSL5 amide (mouse) | 8351 | ||||||||
INSL5 analogue 13 | 11915 | ||||||||
INSL5-A13NR | 11919 | ||||||||
INSL3 B-chain analogue | 3885 | ||||||||
INSL3 B chain dimer analogue 8 | 4372 | ||||||||
[125I]INSL3 (human) |
![]() |
![]() |
1996 | ||||||
[125I]INSL5 (human) |
![]() |
![]() |
2001 | [125I]insulin-like peptide 5 | |||||
insulin glargine |
![]() |
7572 | HOE-901, HOE901, Lantus® | ||||||
[125I](3-iodo-Tyr13)-MCH |
![]() |
![]() |
1316 | ||||||
[3-iodo-Tyr6]U-II-(4-11) (human) | 9436 | ||||||||
ipafricept | 10325 | FZD8-Fc, OMP-54F28, OMP54F28 | |||||||
iPep-SARS2-E | 13253 | TAT-MY18-2ED | |||||||
IPL344 | 13268 | IPL-344 | |||||||
[3H]-IPP |
![]() |
![]() |
11368 | ||||||
IRL 2500 |
![]() |
3887 | IRL-2500, IRL2500 | ||||||
[125I]IRL1620 |
![]() |
![]() |
1007 | [125I]-IRL1620, [125I]IRL 1620 | |||||
iseganan | 10822 | IB-367, IB-367-03 | |||||||
isopropylureido-FLFLF | 1041 | ||||||||
Isox-Cha-Chg-Ala-Arg-Dpr(4FB)-NH2 | 12492 | ||||||||
Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2 |
![]() |
12493 | |||||||
isunakinra |
![]() |
9704 | EBI-005 | ||||||
iturelix | 3854 | antide, D 21074, ORF 23541 | |||||||
[125I-Tyr]Ac2-26 |
![]() |
![]() |
6198 | [125I]ANXA1-derived peptide | |||||
J | Back to top | ||||||||
J18 (galanin analogue) | 6075 | ||||||||
J20 (galanin analogue) | 6076 | ||||||||
JI-38 | 6523 | [Dat1,Gln8,Orn12,21,Abu15,Nle27Asp28,Agm29]hGH-RH-(1-29) | |||||||
jingzhaotoxin-III | 2574 | β-theraphotoxin-Cj1a, β-TRTX-Cj1a, Jingzhaotoxin-3, JZTX-III | |||||||
jingzhaotoxin-XI | 2575 | κ-theraphotoxin-Cj1a, κ-TRTX-Cj1a, Jingzhaotoxin-11, JZTX-11, JZTX-XI | |||||||
JMR-132 | 9114 | ||||||||
JMV1116 | 670 | JMV 1116, JMV-1116 | |||||||
JMV1431 | 656 | JMV 1431, JMV-1431 | |||||||
JMV180 | 3888 | Boc-Tyr(SO3H)Ahx-Gly-Trp-Ahx-Asp2phenylethyl ester, JMV 180, JMV-180 | |||||||
JMV2004 | 1568 | JMV 2004, JMV-2004 | |||||||
JMV310 | 898 | JMV 310, JMV-310 | |||||||
JMV431 | 1569 | JMV 431, JMV-431 | |||||||
JMV449 | 1570 | JMV 449, JMV-449 | |||||||
JMV457 | 1571 | tert-butoxy-carbonyl-Arg-Arg-Pro-D-Tyr-Ile-Leu-OH, JMV 457 | |||||||
JMV458 | 1572 | JMV 458, JMV-458 | |||||||
JMV594 | 624 | [D-Phe6,Statine13]Bombesin(6-14), JMV 594 | |||||||
JMV641 | 3889 | JMV 641, JMV-641 | |||||||
JPE1375 | 5763 | JPE 1375 | |||||||
JV-1-10 | 1106 | [PhAc-Tyr1,D-Arg2,Phe(4-Cl)6,Arg9,Abu15,Nle27, D-Arg29]hGH-RH(1-29)NH2 | |||||||
JV-1-36 | 1107 | [PhAc-Tyr1,D-Arg2,Phe(4-Cl)6,Arg9,Abu15,Nle27,D-Arg28,Har29]hGH-RH(1-29)NH2, JV 1-36 | |||||||
JV-1-37 | 1108 | ||||||||
JV-1-38 | 1109 | JV 1-38 | |||||||
JV-1-39 | 1110 | ||||||||
JV-1-40 | 1111 | ||||||||
JV-1-41 | 1112 | ||||||||
JV-1-42 | 1113 | JV 1-42 | |||||||
JV-1-43 | 1114 | ||||||||
JV-1-62 | 1115 | ||||||||
JV-1-63 | 1116 | JV 1-63 | |||||||
K | Back to top | ||||||||
K31440 | 3890 | Ac-(D-Tyr11,His12,Nle17)sauvagine(11-40), K 31440, K-31440 | |||||||
K41498 | 3891 | [D-Phe11,His12,Nle17]sauvagine(11-40), K 41498, K-41498 | |||||||
kaliotoxin | 2546 | BmKTX, KTX, potassium channel toxin α-KTx 3.6 | |||||||
kassinin | 2088 | ||||||||
KBP-066 | 10660 | DACRA, KBP 066, KBP066 | |||||||
KBP-088 | 10683 | DACRA, KBP 088, KBP088, KeyBiosciencePeptide 088 | |||||||
[125I]KC-Tyr |
![]() |
![]() |
832 | ||||||
KE 108 | 2013 | KE-108, KE108 | |||||||
KH28 | 5306 | KH 28, KH-28 | |||||||
kisspeptin-15 | 1286 | KP-15 | |||||||
kisspeptin-28 | 1287 | KP-28 | |||||||
kisspeptin-9 | 1289 | KP-9 | |||||||
[125I]kisspeptin-10 (human) |
![]() |
![]() |
1281 | [125I]-KP10, [125I]KP-10 | |||||
[125I]kisspeptin-13 (human) |
![]() |
![]() |
3792 | [125I]-kisspeptin13, [125I]-KP13, [125I]KP13 | |||||
[125I]kisspeptin-14 (human) |
![]() |
![]() |
4013 | [125I]KP14 | |||||
[125I]kisspeptin-54 (human) |
![]() |
![]() |
1282 | [125I]KP-54, [125I]metastin | |||||
α-KTx 13.2 | 2550 | OsK2 | |||||||
γ-KTx1.7 | 7689 | CeErg4, potassium channel toxin gamma-KTx 1.7 | |||||||
kurtoxin | 2521 | Ktx | |||||||
L | Back to top | ||||||||
L-156,602 | 577 | L 156602, PD 124966 | |||||||
L-362,823 | 2072 | L 362823, L-362823 | |||||||
L-362,855 | 2014 | L 362855, L-362855 | |||||||
L-363,301 | 2047 | L 363301, L 363568, MK 301, MSD-L 363301 | |||||||
L-363,377 | 2048 | L 363377, L-363377 | |||||||
L-363,409 | 2049 | L 363409, MK 363-409 | |||||||
L-365,209 | 2241 | L 365209, L-365209 | |||||||
L-366,682 | 2243 | cyclo(Pro-Trp-Ile-Pip-Pip-His), L 366682 | |||||||
L-366,875 | 2244 | L 366875, L-366875 | |||||||
L-366,948 | 2245 | L 366948, L-366948 | |||||||
labradimil | 672 | [Hyp3,Thi5,4-Me-Tyr8ψ(CH2-NH)Arg9]bradykinin, cereport, lobradimil, RMP-7 | |||||||
lactomedin 1 | 10228 | ||||||||
lanreotide |
![]() |
2031 | BIM 23014, DC 13-116, lanreotide acetate, Somatuline® | ||||||
larazotide | 13724 | AT-1001, AT-2347, AT1001, AT2347 | |||||||
Large proline-rich protein BAG6 |
![]() |
11143 | BAG6 | ||||||
lasso D | 5899 | ||||||||
α-latrotoxin | 5897 | alpha-LTX, alpha-latrotoxin, alpha-latrotoxin-Lt1a, alpha-LTX-Lt1a | |||||||
[L-Bpa5,Ile13]motilin (human) | 1451 | ||||||||
LCB1 | 11236 | ||||||||
LCB3 | 11237 | ||||||||
LDV-FITC |
![]() |
6759 | |||||||
Lei-Dab7 | 2315 | ||||||||
leiurotoxin I | 2316 | Leiurotoxin-1 (LeTx1), potassium channel toxin α-KTx 5.1, scyllatoxin (ScyTx) | |||||||
lepirudin |
![]() |
6469 | 1-L-leucine-2-L-threonine-63-desulfohirudin, Refludan® | ||||||
[Leu14]bombesin | 11259 | ||||||||
[Leu14, ψ 13-14)]bombesin | 629 | ||||||||
[Leu8,des-Arg9]bradykinin | 641 | ||||||||
[Leu9,des-Arg10]kallidin | 642 | [Lys,Leu8,des-Arg9]bradykinin, Lys-[Leu8][des-Arg9]BK, Lys-[Leu8][des-Arg9]bradykinin | |||||||
[Leu13]motilin (human) | 1453 | ||||||||
[3H]Leu-N/OFQ |
![]() |
![]() |
3824 | [3H]-Leu-N/OFQ, [3H]-Leu-nociceptin.orphanin FQ | |||||
[Leu8]-phyllolitorin | 6168 | ||||||||
leuprolide |
![]() |
1175 | ABBOTT-43818, Camcevi®, Fensolvi® (leuprolide acetate injectable suspension), Lupron®, TAP-144 | ||||||
[Leu31,Pro34]NPY | 1545 | [Leu31,Pro34] neuropeptide Y, [Leu31,Pro34]-NPY | |||||||
[125I][Leu31,Pro34]NPY |
![]() |
![]() |
3762 | [125I]-[Leu31,Pro34]neuropeptide Y, [125I]-[Leu31,Pro34]NPY | |||||
[Leu31,Pro34]NPY (pig) | 1524 | porcine [Leu31,Pro24] neuropeptide Y, porcine [Leu31,Pro34] neuropeptide Y | |||||||
[Leu31,Pro34]PYY (human) | 1527 | human [Leu31,Pro34] peptide tyrosine tyrosine, human [Leu31,Pro34] peptide YY | |||||||
[Leu31,Pro34]PYY (pig) | 1526 | [Leu31,Pro34] peptide tyrosine tyrosine, [Leu31,Pro34] peptide YY | |||||||
LGR7-truncate | 3893 | ||||||||
[125I]LH |
![]() |
![]() |
3793 | [125I]-LH, [125I]-luteinising hormone, [125I]-luteinizing hormone | |||||
LIH383 | 11084 | ||||||||
linaclotide |
![]() |
5017 | Constella®, Linzess®, MM-416775 | ||||||
liraglutide |
![]() |
1133 | NN-2211 , NN2211, NNC 90-1170, NNC-90-1170, Victoza® | ||||||
litorin | 617 | litorine | |||||||
livoletide | 10884 | AZP-531, AZP531, Cyclo(des-acyl ghrelin(6-13)), Des-acyl ghrelin | |||||||
lixisenatide |
![]() |
7387 | Adlyxin®, AVE-0010, Lyxumia® | ||||||
[3H]-LKP |
![]() |
![]() |
11369 | ||||||
L-Phe-Phe-Phe | 12435 | ||||||||
L-Trp-Trp-Trp | 12424 | ||||||||
[125I]LTT-SRIF-28 |
![]() |
![]() |
2023 | 3-[125I](Leu8, D-Trp22, Tyr25)somatostatin-28, 3-[125I]LTT-SRIF-28, [125I](Leu8, D-Trp22, Tyr25)-somatostatin-28 | |||||
LTX(N4C) | 5898 | latrotoxin(N4C) | |||||||
[L-Tyr8]CYN 154806 | 2029 | cyanamid 154806 | |||||||
LUNA18 | 12931 | compound 45 [PMID: 37463267] | |||||||
luspatercept |
![]() |
10538 | ACE-536, ACE536, luspatercept-aamt, Reblozyl® | ||||||
LV-2172 | 9442 | ||||||||
LV-2186 | 10252 | compound 5b | |||||||
LV-2211 | 12420 | [Tic22]26RFa(20-26), analog 28 [PMID: 34299587] | |||||||
LVP {Sp: Pig} | 2172 | [Lys8]-vasopressin, [Lys8]AVP, lysine vasopressin, syntopressin | |||||||
LY3463251 | 12843 | ||||||||
LY3540378 | 12502 | ||||||||
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2 | 3842 | [K15, Arg16, Leu27]VIP(1-7)/GRF(8-27) | |||||||
Lys-CoA | 7036 | Ac-Lys(CoA)-NH2 | |||||||
[3H]Lys-[des-Arg9]BK |
![]() |
![]() |
3825 | [3H]-Lys-[des-Arg9]-bradykinin, [3H]-Lys-[des-Arg9]BK | |||||
Lys-kallidin | 637 | [Lys,Lys]bradykinin | |||||||
[3H]Lys-[Leu8][des-Arg9]BK |
![]() |
![]() |
3826 | [3H]-Lys-[Leu8][des-Arg9]-bradykinin, [3H]-Lys-[Leu8][des-Arg9]BK | |||||
[19Lys,26Leu]-galparan | 6097 | ||||||||
[Lys5,Me-Leu9,Nle10]NKA-(4-10) | 3843 | [Lys5,Me-Leu9,Mle10]neurokinin A(4-10) | |||||||
Lys[Z(NO2)]-Val | 9486 | ||||||||
M | Back to top | ||||||||
M1145 | 6101 | ||||||||
M1151 | 6102 | GWTLNSAGYLLGPK(ε-NH-C(O)X)-amide | |||||||
M1152 | 6103 | WTLNSAGYLLGPK(ε-NH-C(O)X)-amide | |||||||
M1153 | 6104 | RGRGNWTLNSAGYLLGPK(ε-NH-C(O)X)-amide | |||||||
M1160 | 6074 | ||||||||
M15 | 3896 | galanin(1-13)substance P(5-11)amide, galantide | |||||||
M242 | 6099 | M 242, M-242 | |||||||
M32 | 3897 | galanin(1-13)neuropeptide Y-amide(25-36)amide | |||||||
M35 | 3898 | galanin(1-13)bradykinin(2-9)amide | |||||||
M372049 | 5020 | M 372049, M-372049 | |||||||
M40 | 3899 | galanin(1-13)Pro-Pro-Ala-Leu-Ala-Leu-Ala-Leu-Ala-amide | |||||||
M617 | 6100 | ||||||||
M65 | 3305 | des-(Gln25-Gln41)-maxadilan, maxadilan Δ25-41 | |||||||
M871 | 3900 | galanin(2-13)Glu-His-(Pro)3(Ala-Leu)2Ala-amide | |||||||
maltotriose-[125I][Tyr3,Thr8]octreotide |
![]() |
![]() |
5631 | [125I]-Mtr-TOCA, maltotriose-[125I]-Tyr3-octreotate | |||||
mambalgin-1 | 10308 | ||||||||
mamba toxin CM-3 | 13153 | Adrenergic toxin rho-elapitoxin-Dp1b, rho-EPTX-Dp1b | |||||||
margatoxin | 2547 | MgTx, potassium channel toxin α-KTx 2.2 | |||||||
mast cell degranulating peptide | 2548 | MCD peptide, MCDP, Peptide 401 | |||||||
maurotoxin | 2332 | MTX, potassium channel toxin α-KTx 6.2 | |||||||
maxadilan | 2264 | ||||||||
Max.d.4 | 2265 | des-(Leu24-Leu42)-maxadilan, maxadilan Δ24-42 | |||||||
MBP10 | 1339 | MBP 10, MBP-10 | |||||||
MBP7 | 7038 | ||||||||
MCH6-17 | 1293 | melanin-concentrating hormone (6-17) | |||||||
[125I]MCH (human, mouse, rat) |
![]() |
![]() |
1296 | [125I]-melanin-concentrating hormone | |||||
[3H]MCH (human, mouse, rat) |
![]() |
![]() |
3827 | [3H]-MCH, [3H]-melanin-concentraing hormone | |||||
MCH (salmon) | 1301 | salmon melanin-concentrating hormone | |||||||
κM-conotoxin RIIIK | 11476 | κM-RIIIK, kappaM-RIIIK | |||||||
MC148R | 778 | MC 148, MC 148 CC chemokine | |||||||
MD5 | 13458 | compound B [PMID: 39028865] | |||||||
MEN 10376 | 2116 | [Tyr5,D-Trp6,8,9,Lys10]-alpha-NEUROKININ A, Fragment 4-10, MEN-10,376, MEN-10376, neurokinin A(4-10), Tyr(5)-Trp(6,8,9)-Lys(10)- | |||||||
MEN10627 | 3901 | cyc(2β-5β)(Met-Asp-Trp-Phe-Dap-Leu), MEN-10627 | |||||||
[125I][MePhe7]NKB |
![]() |
![]() |
3763 | [125I]-[MePhe7]neurokinin A, [125I]-[MePhe7]NKB | |||||
Met-Ckβ7 | 788 | Ckβ7, Met-chemokine β 7 | |||||||
[Met5]dynorphin-(1-17) | 1659 | ||||||||
Met-Lys-bradykinin | 638 | Met-kallidin | |||||||
Met-Met-Trp-Leu-Leu | 5836 | ||||||||
metreleptin |
![]() |
7333 | Myalept®, r-metHuLeptin, R-methuleptin | ||||||
MG-101 |
![]() |
13381 | MG101, N-acetyl-L-leucyl-L-leucyl-L-norleucinal | ||||||
MG-115 | 11639 | Cbz-Leu-Leu-norvalinal, N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-norvalinal, Z-LL-Nva-CHO | |||||||
MG-132 |
![]() |
8616 | compound 5b [PMID: 16686537], MG132, N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal, Z-Leu-leu-leu-al, Z-LLL-CHO | ||||||
mGIPAnt-1 | 11998 | ||||||||
MHC binding peptide | 6250 | ||||||||
mideplanin | 10830 | CTA A1, MDL 62873, MDL-62873, MDL62873 | |||||||
minimised INSL5 analogue 7 | 8334 | ||||||||
minimised INSL5 analogue 7 A chain | 8335 | ||||||||
minimised relaxin-3 analogue 2 | 8336 | ||||||||
minimised relaxin-3 analogue 3 | 8326 | ||||||||
minimised relaxin-3 analogue A chain | 8327 | minimised relaxin-3 analogue 2 A chain, minimised relaxin-3 analogue 3 A chain | |||||||
minimised relaxin-3 analogue 3 B chain | 8328 | ||||||||
mini-TyrRS | 823 | NH2-terminal catalytic domain of human tyrosyl-tRNA synthetase | |||||||
[125I]mini-TyrRS |
![]() |
![]() |
818 | 125I-NH2-terminal catalytic domain of human tyrosyl-tRNA synthetase | |||||
MIT1 | 1865 | mamba intestinal toxin-1 | |||||||
MK-7110 |
![]() |
11395 | CD24-Fc, CD24Fc | ||||||
[125I]MK-678 |
![]() |
![]() |
2061 | ||||||
MLCK inhibitor peptide 18 | 9351 | Myosin Light Chain Kinase Inhibitor Peptide 18 | |||||||
MM07 | 8523 | cyclo[1-6]CRPRLCHKGPMPF | |||||||
MM54 | 6186 | cyclo(1-6)CRPRLC-KH-cyclo(9-14)CRPRLC | |||||||
MMK-1 |
![]() |
6240 | MMK 1 | ||||||
motilin {Sp: Dog} | 1457 | ||||||||
motilin {Sp: Rabbit} | 1459 | ||||||||
motilin-(1-11) (human) | 1460 | motilin1-11 (human) | |||||||
motilin-(1-12) (human) | 1461 | motilin1-12 (human) | |||||||
motilin-(1-13) (human) | 1462 | motilin1-13 (human) | |||||||
motilin-(1-19) (human) | 1463 | motilin1-19 (human) | |||||||
motilin-(2-22) (human) | 1464 | motilin2-22 (human) | |||||||
[125I]motilin (human) |
![]() |
![]() |
3794 | [125I]-motilin | |||||
motixafortide |
![]() |
![]() |
10679 | 4F-Benzoyl-TN14003, Aphexda®, BKT140, BL-8040, TF14016 | |||||
[Mpa1,D-Tyr(Et)2,D-Tic7,Aib9]OT | 2255 | [deamino β-mercaptopropionic acid,-D-Tyr2,D-Tic7,Aib9]OT, [Mpa1,O-ethyl-D-Tyr2,D-Tic7,Aib9]OT | |||||||
[Mpa1,D-Tyr(Et)2,D-Tic7,D-Tic9]OT | 2254 | [deamino β-mercaptopropionic acid,D-Tyr(Et)2,D-Tic7,D-Tic9]OT, [Mpa1,O-ethyl-D-Tyr2,D-Tic7,D-Tic9]OT | |||||||
[Mpa1,D-Tyr(Et)2,D-Tic7]OT | 2256 | [deamino β-mercaptopropionic acid-D-Tyr(Et)2,D-Tic7]OT | |||||||
MS05 | 1322 | ||||||||
MT-II | 1323 | melanotan II, MTII | |||||||
multi-Leu (ML)-peptide | 8648 | ML-peptide | |||||||
murepavadin | 10832 | POL7080, RG-7929, RG7929, RO-7033877, RO7033877 | |||||||
muscarinic toxin 1 | 311 | MT1, MTx1 | |||||||
muscarinic toxin 2 | 312 | MT2, MTx2 | |||||||
muscarinic toxin 3 | 313 | mamba toxin-3, MT3 | |||||||
muscarinic toxin 7 | 314 | m1-toxin 1, MT7, recombinant mamba venom toxin, rMT7 | |||||||
muscarinic toxin β | 13152 | Adrenergic toxin rho-elapitoxin-Dp1a, MTβ, rho-EPTX-Dp1a | |||||||
mutant ANP | 10211 | mANP, mutant atrial natriuretic peptide | |||||||
myr-PKI | 10619 | Protein kinase inhibitor-(14-22)-amide, myristoylated | |||||||
MZ-4-169 | 1117 | [Nac0,D-Arg2,Phe(4-Cl)6,Abu15,Nle27]hGHRH-(1-29) NH2 | |||||||
MZ-4-181 | 1118 | [Nac0-His1,D-Arg2,Phe(4-Cl)6,Abu15,Nle27]-hGH RH-(1-29)NH2 | |||||||
MZ-4-243 | 1119 | [Nac0,D-Arg2,Phe(4-CI)6,Abu15,Nle27]hGHRH-(1-28)Agm | |||||||
MZ-4-71 | 1120 | MZ 4-71 | |||||||
MZ-5-156 | 1121 | MZ 5-156 | |||||||
MZ-5-192 | 1122 | ||||||||
MZ-5-78 | 1123 | ||||||||
MZ-6-55 | 1124 | [PhAc-Tyr1,D-Arg2,Phe(4-Cl)6,Abu15,Nle27,D-Arg28,Har29]hGH-RH(1-29)NH2, MZ 6-55 | |||||||
N | Back to top | ||||||||
N-0385 | 11956 | example 2 [WO2018112648A1], Ms-QFR-Kbt, N0385 | |||||||
N36 | 6246 | ||||||||
NAB739 | 13588 | ||||||||
N-Aβcore hexapeptide | 13244 | N-Aβ(10-15), N-Aβ10-15, N-Aβcore | |||||||
N-α-Ac-PYY-(22-36) (rat) | 1532 | N-α-Ac-PYY22-36 (rat) | |||||||
N-α-Ac-PYY-(25-36) (rat) | 1533 | N-α-Ac-PYY25-36 (rat) | |||||||
nafarelin |
![]() |
3902 | Synarel® | ||||||
Nanoluciferase-labelled relaxin |
![]() |
11464 | |||||||
NanoLuc-INSL3 |
![]() |
11913 | |||||||
NanoLuc R3/I5 chimera |
![]() |
11465 | |||||||
[125I]N-biotin-[Ahx0, Bpa3]U-II (human) |
![]() |
![]() |
9440 | ||||||
NC 8-12 | 2052 | ||||||||
NC 4-28B | 2017 | ||||||||
5nd | 8723 | ||||||||
[125I]NDP-MSH |
![]() |
![]() |
1326 | [125I]-NDP-MSH, [125I][Nle4,dPhe7]α-MSH | |||||
nepadutant | 2123 | LS-55819, MEN 11420, MEN-11420, MEN11420 | |||||||
nerinetide | 12332 | NA-1, Tat-NR2B9c | |||||||
neuromedin B (1-30) (human) | 6163 | NMB30 | |||||||
neuromedin C | 6178 | NMC | |||||||
neuromedin U-8 {Sp: Dog} | 1472 | NmU-8, canine neuromedin U-8 | |||||||
neuromedin U-25 {Sp: Pig} | 1471 | NmU-25, porcine neuromedin U-25 | |||||||
neuromedin U-8 {Sp: Pig} | 1473 | NmU-8, NMU-8, porcine neuromedin U-8 | |||||||
[125I]neuromedin U-25 (human) |
![]() |
![]() |
1474 | [125I]NmU-25 (human), [125I]neuromedin U, [125I]NMU-25 | |||||
[125I]neuromedin U-8 (pig) |
![]() |
![]() |
1476 | [125I]NmU-8 (pig), porcine [125I]neuromedin U-8 | |||||
[125I]neuromedin U-23 (rat) |
![]() |
![]() |
1475 | [125I]NmU-23 (rat), rat [125I]neuromedin U-23 | |||||
neuropeptide-γ | 2092 | ||||||||
neuropeptide head activator | 2496 | HA | |||||||
neurotensin-(8-13) | 7363 | ||||||||
[125I]neurotensin (human, mouse, rat) |
![]() |
![]() |
1574 | [125I]NT | |||||
[3H]neurotensin (human, mouse, rat) |
![]() |
![]() |
3830 | [3H]-neurotensin | |||||
NG29 | 10254 | SarLys[DPhe8]desArg9-bradykinin | |||||||
NG291 | 10255 | [Hyp3,Thi5,NChg7,Thi8]-bradykinin | |||||||
[125I]NGF (human) |
![]() |
![]() |
4849 | [125I]-nerve growth factor | |||||
[125I]NKA (human, mouse, rat) |
![]() |
![]() |
3795 | [125I]-neurokinin A, [125I]-NKA | |||||
[125I][Nle75,Tyr77]apelin-36 (human) |
![]() |
![]() |
603 | ||||||
[Nle8,18,Tyr34]PTH-(1-34)-NH2 (bovine) | 1805 | ||||||||
[Nle8,18,Tyr34]PTH-(3-34)-NH2 (bovine) | 1806 | ||||||||
[125I][Nle8,21,Tyr34]PTH-(1-34)-NH2 (rat) |
![]() |
![]() |
1791 | ||||||
[nLeu13,Glu14]motilin (human) | 1455 | ||||||||
NM4-C16 | 9009 | ||||||||
[N-Me,des-Sar]Gal-B2 | 6109 | ||||||||
N-methyl-Phe-Lys-Pro-D-Cha-Cha-D-Arg-CO2H | 572 | ||||||||
N-methyl-Phe-Lys-Pro-D-Cha-Trp-D-Arg-CO2H | 576 | ||||||||
NMU (104-114) | 10569 | ||||||||
NN1213 | 13441 | NN-1213, peptide 21 [PMID: 38960379] | |||||||
NNC1702 | 9760 | des-His1-[Glu9, Lys24(4 X γGlu), Leu27]glucagon | |||||||
NOC-ATE | 2053 | ||||||||
N-octanoyl-L-homoserine lactone |
![]() |
12447 | C8-HSL, Octanoyl-L-homoserine lactone | ||||||
NODAGA-[Tyr3]-octreotide | 5627 | NODAGA-Tyr3-octreotide, NODAGATOC | |||||||
[67Ga]NODAGA-[Tyr3]octreotide |
![]() |
![]() |
5628 | [67Ga]-NODAGA-Tyr3-octreotide, Ga-NODAGATOC | |||||
[3H]N/OFQ |
![]() |
![]() |
1688 | [3H]nociceptin, [3H]nociceptin/orphanin FQ, [3H]orphanin FQ | |||||
N/OFQ-(1-13)-NH2 | 1682 | nociceptin(1-13)NH2, nociceptin/orphanin FQ(1-13)NH2, orphanin FQ(1-13)NH2 | |||||||
N/OFQ-NH2 | 1683 | nociceptin-NH2, nociceptin/orphanin FQ--NH2, orphanin FQ-NH2 | |||||||
nogapendekin alfa | 11594 | IL15 D72 | |||||||
NOSO-502 | 13157 | ||||||||
novokinin | 6893 | ||||||||
noxiustoxin | 2552 | NTx, potassium channel toxin α-KTx 2.1, Toxin II.11 | |||||||
NPC 17731 | 657 | D-Arg[Hyp3,trans-4-propoxy-D-proline(transpropyl)7,Oic8]bradykinin, NPC-17731, NPC17731 | |||||||
NPC 18565 | 658 | [D-Arg(Hyp3,D-Hyp7(transpropyl),Oic8)des-Arg9]bradykinin, des-Arg9 fragment of NPC 17731, NPC-18565, NPC18565 | |||||||
NPC-349 | 675 | [D-Arg0,Hyp2,3,Thi5,8,D-Phe7]bradykinin, NPC 349 | |||||||
NPC-567 | 676 | [D-Arg0,Hyp3,D-Phe7]bradykinin, BIM 31006, NPC 567 | |||||||
[3H]NPC17731 |
![]() |
![]() |
3831 | [3H]-NPC17731 | |||||
[125I]NPFF |
![]() |
![]() |
3797 | [125I]-neuropeptide FF, [125I]-NPFF | |||||
[Nphe1]N/OFQ-(1-13)-NH2 | 1695 | [Nphe1]nociceptin(1-13)NH2, [Nphe1]nociceptin/orphanin FQ(1-13)NH2, [Nphe1]orphanin FQ(1-13)NH2 | |||||||
3-N3-Phpa-LVA | 2193 | ||||||||
[125I]3-N3-Phpa-LVA |
![]() |
![]() |
2206 | ||||||
NPS(1-4)NH2 | 11226 | peptide 3 [PMID: 28267583], PEPTIDE1{S.F.R.N.[am]}$$$$ | |||||||
[3H]NPVF |
![]() |
![]() |
4019 | [3H]-NPVF, [3H]neuropeptide VF | |||||
[125I]NPW-23 (human) |
![]() |
![]() |
1497 | [125I]neuropeptide W, [125I]neuropeptide W-23, [125I]NPW | |||||
NPY {Sp: Pig} | 1505 | porcine neuropeptide Y | |||||||
NPY-(13-36) | 3903 | neuropeptide Y (13-36) | |||||||
NPY-(2-36) | 1549 | neuropeptide Y (2-36) | |||||||
NPY-(13-36) (human) | 1535 | human neuropeptide Y (13-36) | |||||||
[125I]NPY (human, mouse, rat) |
![]() |
![]() |
1518 | [125I]neuropeptide Y | |||||
[3H]NPY (human, mouse, rat) |
![]() |
![]() |
1521 | [3H]neuropeptide Y | |||||
NPY-(18-36) (human, pig) | 1557 | human neuropeptide Y (18-36), porcine neuropeptide Y (18-36) | |||||||
NPY-(13-36) (pig) | 1507 | porcine neuropeptide Y (13-36) | |||||||
NPY-(16-36) (pig) | 1536 | porcine neuropeptide Y (16-36) | |||||||
NPY-(20-36) (pig) | 1538 | porcine neuropeptide Y (20-36) | |||||||
NPY-(22-36) (pig) | 1539 | porcine neuropeptide Y (22-36) | |||||||
NPY-(2-36) (pig) | 1508 | porcine neuropeptide Y (2-36) | |||||||
NPY-(26-36) (pig) | 1540 | porcine neuropeptide Y (26-36) | |||||||
NPY-(3-36) (pig) | 1510 | porcine neuropeptide Y (3-36) | |||||||
Nrf2 peptide [PMID: 23647822] | 8772 | ||||||||
N-stearyl-[Nle17] neurotensin-(6-11)/VIP-(7-28) | 2266 | (SN)VIPhybrid, N-stearyl-[Nle17] neurotensin(6-11)/VIP(7-28) | |||||||
N-stearyl-[Nle17]VIP | 2271 | N-stearyl-[Nle17]vasoactive intestinal peptide | |||||||
NX210 | 13257 | NX-210, NX-210c, NX210c, SCO-spondin derived peptide NX210 | |||||||
O | Back to top | ||||||||
obtustatin | 6581 | ||||||||
ocriplasmin |
![]() |
7446 | Jetrea®, microplasmin | ||||||
Octpep-1 | 12265 | ||||||||
octreotide |
![]() |
2055 | DRG-0115, Mycapssa®, Sandostatin®, SMS 201,995 | ||||||
OH-LVA | 2195 | ||||||||
[125I]OH-LVA |
![]() |
![]() |
2207 | ||||||
OHM-11526 | 1467 | [Phe3,Leu13]motilin (porcine) | |||||||
olamkicept |
![]() |
9729 | FE 999301, FE-301, FE-999301, TJ301 | ||||||
ontorpacept | 12036 | TTI-621, TTI621 | |||||||
opiorphin | 11538 | Gln-Arg-Phe-Ser-Arg, L-Glutaminyl-L-arginyl-L-phenylalanyl-L-seryl-L-arginine, QRFSR peptide | |||||||
oprelvekin |
![]() |
![]() |
6971 | Neumega® | |||||
[125I]orexin A (human, mouse, rat) |
![]() |
![]() |
3798 | [125I]-orexin A | |||||
[Orn5]URP | 9438 | ||||||||
oryzatensin | 10227 | ||||||||
OSK1-K16-D20 | 2556 | [K16,D20]-OSK1 | |||||||
OSTN (115-133) | 10570 | ||||||||
OSTN (81-102) | 10573 | ||||||||
[3H]OT (human, mouse, rat) |
![]() |
![]() |
2176 | [3H]oxytocin | |||||
P | Back to top | ||||||||
P05 | 2325 | AmP05, leiurotoxin I-like toxin P05, Potassium channel toxin α-KTx 5.2 | |||||||
P11 | 6595 | ||||||||
PACAP-(6-38) | 2267 | pituitary adenylate cyclase activating polypeptide (6-38) | |||||||
[125I]PACAP-27 |
![]() |
![]() |
2261 | [125I]-PACAP-27, [125I]pituitary adenylate cyclase activating polypeptide-27 | |||||
palifermin |
![]() |
6954 | Kepivance®, keratinocyte growth factor | ||||||
palopegteriparatide |
![]() |
13484 | mPEG-PTH (1-34), TransCon PTH, Yorvipath® | ||||||
Pam2CSK4 |
![]() |
8560 | |||||||
Pam3CSK4 |
![]() |
8558 | |||||||
[p-aminoPhe6]ang II | 595 | [p-aminoPhe6] angiotensin II | |||||||
PAMP-12 (human) | 4056 | Human PAMP(9-20), proadrenomedullin N-terminal 20 Peptide (Human, 9-20) | |||||||
pancreatic polypeptide {Sp: Bovine} | 1511 | PP, bovine pancreatic polypeptide | |||||||
pancreatic polypeptide {Sp: European common frog} | 1480 | PP, frog pancreatic polypeptide | |||||||
pandinotoxin-K α | 2553 | potassium channel toxin α-KTx 7.1, potassium channel-blocking toxin 2, toxin PiTX-K-α | |||||||
pasireotide |
![]() |
2018 | pasireotide diaspartate, Signifor®, SOM 230, SOM 320, SOM-230 | ||||||
PBC-264 | 3948 | pBC 264, propionyl-BC264 | |||||||
[3H]PBC-264 |
![]() |
![]() |
899 | [3H]-Propionyl-BC-264, [3H]-Propionyl-BC264, [3H]propionyl-BC-264 | |||||
PBP10 | 1043 | PBP 10 | |||||||
pCXCL8-1aa |
![]() |
9938 | |||||||
[125I]PD151242 |
![]() |
![]() |
1001 | [125I](N-[{hexahydro-1-azepinyl}carbonyl])Leu(1-Me)-DTrp-DTyr, [125I]-PD151242 | |||||
peceleganan | 13758 | PL-5, V681 | |||||||
pegcetacoplan |
![]() |
![]() |
13826 | APL-2, Empaveli® | |||||
pegdinetanib | 10472 | Angiocept®, BMS-844203, BMS844203, CT-322, CT322 | |||||||
pegfilgrastim |
![]() |
6969 | Neulasta® | ||||||
peginesatide |
![]() |
7447 | AF37702, Hematide®, Omontys® | ||||||
peginterferon alfa-2b |
![]() |
![]() |
7462 | PegIntron®, Sylatron® | |||||
peginterferon beta-1a |
![]() |
![]() |
7637 | interferon beta 1-alpha, PEG-INF-β-1a, Plegridy® | |||||
pegloticase |
![]() |
7463 | Krystexxa®, puricase | ||||||
PEG40-NMU | 7928 | ||||||||
pegvisomant |
![]() |
7485 | B2036-PEG, Somavert® | ||||||
pentagastrin |
![]() |
870 | AY-6608, ICI-50123, Peptavlon® | ||||||
[Pen5]U-(4-11) (human) | 2160 | human [Pen5]-urotensin (4-11) | |||||||
pepcan-12 | 9188 | ||||||||
peptide 234 | 4012 | ||||||||
peptide 5A | 10588 | ||||||||
peptide Cp40 [PMID: 25982307] |
![]() |
9220 | peptide 14 | ||||||
peptide III-BTD | 1696 | ||||||||
peptide KLK2b(c1) | 8484 | ||||||||
peptide ligand 2 [PMID: 19055415] | 8849 | (cdGTyr(3-NO2)GBNc, LXY3 | |||||||
peptide 14 [PMID: 36580549] | 12333 | ||||||||
peptide 30 [PMID: 27019010] |
![]() |
9253 | |||||||
Peptide 5 [PMID: 28562585] | 9588 | ||||||||
peptide P19 [PMID: 15652659] | 9163 | [Ser11](N-CNP,C-ANP)pBNP(2-25) | |||||||
petrelintide | 13804 | ZP-8396, ZP8396 | |||||||
[(pF)Phe4]N/OFQ-(1-13)-NH2 | 1686 | [(pF)Phe4]nociceptin(1-13)NH2, [(pF)Phe4]nociceptin/orphanin FQ(1-13)NH2, [(pF)Phe4]orphanin FQ(1-13)NH2, peptide 4a | |||||||
PG-106 | 6546 | PG 106, PG106 | |||||||
PG-901 | 1341 | PG 901, PG901 | |||||||
PG 97-269 | 2268 | [Acetyl-His1,D-Phe2,Lys15,Arg16,Leu17]VIP(3-7)/GRF(8-27) | |||||||
PG 99-465 | 2272 | Myr-His1[Lys12,Lys27,28,Gly29,30,Thr31]VIP, PG99-465 | |||||||
p-guanidinobenzoyl-MCH-(7-17) | 1300 | ||||||||
[Phaa1,D-Tyr(Et)2,Lys6,des-Gly9]AVP | 2208 | ||||||||
[Phaa1,D-Tyr(Et)2,Val4,Lys6,Tyr-NH28,des-Gly9]AVP | 2209 | TyrPhaa | |||||||
[Phaa1,D-Tyr(Me)2,Arg6,Tyr-NH29]AVP | 2210 | ||||||||
[Phaa1,D-Tyr2,Val4,Arg6,Arg-NH29]AVP | 2211 | ||||||||
[Phe13]bombesin | 615 | ||||||||
[Phe8,ψ(CH2-NH)Arg9]BK | 3846 | [Phe8,ψ(CH2-NH)Arg9]bradykinin | |||||||
[Phe3,Leu13]motilin (human) | 1454 | ||||||||
phelorphan | 11655 | deamino-norcysteinyl-L-phenylalanyl-L-phenylalanine | |||||||
[Phe(Me)7]neurokinin B | 2113 | [MePhe7]NKB | |||||||
[Phe3]OT | 2178 | [Phe3]oxytocin, oxypressin | |||||||
[Phe23]PTH-(1-34) (human) | 1807 | ||||||||
[Phe13,Tyr19]MCH | 1297 | [Phe13,Tyr19]-melanin-concentrating hormone | |||||||
[125I][Phe13,Tyr19]MCH |
![]() |
![]() |
3844 | [Phe13,[125I]Tyr19]MCH, [Phe13,[125I]Tyr19]melanin-concentrating hormone | |||||
PHI {Sp: Pig} | 2273 | peptide histidine-isoleucine | |||||||
ω-phonetoxin-IIA | 2540 | ω-phonetoxin-2A, Neurotoxin Tx3-4, Omega-ctenitoxin-Pn3a, Phoneutriatoxin 3-4 | |||||||
[(3-Ph-Pr6), His7,D-Ala11,D-Pro13,ψ13-14),Phe14]bombesin-(6-14) | 627 | ||||||||
phrixotoxin 1 | 2582 | PaTX 1 | |||||||
phrixotoxin 2 | 2583 | κ-theraphotoxin-Ps1b, κ-TRTX-Ps1b, PaTX 2, PaTX2 | |||||||
phyllolitorin | 6166 | [Phe8]-phyllolitorin | |||||||
phyllomedusin | 2093 | ||||||||
physalaemin | 2094 | ||||||||
Pi-hexatoxin-Hi1a | 10306 | π-Hi1a, π-HXTXHi1a, pi-Hi1a | |||||||
Pi-theraphotoxin-Hm3a | 10305 | π-TRTX-Hm3a | |||||||
PL017 | 1671 | 3-N-Me-Phe-morphiceptin, PL 017, PL-017 | |||||||
PL-3994 | 9067 | ||||||||
[3H]PL017 |
![]() |
![]() |
3832 | [3H]-PL017 | |||||
platypus venom heptapeptide 1 | 13200 | ||||||||
plecanatide |
![]() |
9069 | [3-glutamic acid(D>E)]human uroguanylin, SP-304, Trulance® | ||||||
PLG0206 | 13313 | WLBU2 | |||||||
PMX205 |
![]() |
5762 | ALS-205, PMX 205, PMX-205 | ||||||
PMX53 | 579 | Ac-(cyclo-2,6)-F-[OPdChaWR], PMX 53, PMX-53 | |||||||
ω-PnTx3-3 | 2541 | ω-CNTX-Pn2a, ω-ctenitoxin-Pn2a, Neurotoxin Tx3-3, PnTx3-3 | |||||||
PnTx-3-6 | 2542 | ω-CNTX-Pn4a, ω-ctenitoxin-Pn4a, Neurotoxin Tx3-6, PhAlpha-1-beta, PhAlpha-1-beta toxin | |||||||
polybia-MP1 | 8861 | MP1, MP-1 | |||||||
polymyxin B |
![]() |
10338 | Aerosporin® | ||||||
Pomc (141-162) | 10572 | ||||||||
P4pal-10 | 10270 | P4pal10 | |||||||
[PP1-17,Ala31,Aib32]NPY (human) | 1561 | ||||||||
[125I][PP1-17,Ala31,Aib32]NPY (human) |
![]() |
![]() |
1559 | ||||||
P2pal18S | 6659 | P2pal-18S | |||||||
PP-(13-36) (human) | 1550 | human pancreatic polypeptide (13-36) | |||||||
PP-(20-36) (human) | 1552 | human pancreatic polypeptide (20-36) | |||||||
PP-(2-36) (human) | 1551 | human pancreatic polypeptide (2-36) | |||||||
[125I]PP (human) |
![]() |
![]() |
3800 | [125I]-pancreatic polypeptide, [125I]-PP | |||||
P32 [PMID: 27108698] | 9384 | ||||||||
P4 [PMID: 25923432] | 8344 | ||||||||
P59 [PMID: 27108698] | 9385 | ||||||||
P8 [PMID: 25923432] | 8345 | ||||||||
pralmorelin |
![]() |
1092 | GHRP-2, growth hormone-releasing peptide-2, KP 102 | ||||||
pramlintide |
![]() |
7482 | AC0137, Symlin® | ||||||
PRL-2915 | 2066 | PRL 2915 | |||||||
PRL-2970 | 2067 | PRL 2970 | |||||||
pr1 nanopeptide | 8263 | ||||||||
[Pro3]GIP | 3847 | [Pro3]gastric inhibitory polypeptide | |||||||
[Pro7]neurokinin B | 2126 | ||||||||
[Pro34]NPY | 3848 | ||||||||
[Pro34]PYY (human) | 1546 | human [Pro34] peptide tyrosine tyrosine, human [Pro34] peptide YY | |||||||
[Pro9]SP | 3849 | [Pro9]substance P | |||||||
protoxin II | 7571 | β/ω-theraphotoxin-Tp2a, β/ω-TRTX-Tp2a, protoxin-2, ProTx-2, ProTx-II, ProTx2, PT-II | |||||||
PrP106-126 | 6244 | ||||||||
[125I]PrRP31 |
![]() |
![]() |
4022 | [125I]-PrRP31 | |||||
PrRP-(24-31) (human) | 1870 | human prolactin-releasing peptide-24-31 | |||||||
[125I]PrRP-20 (human) |
![]() |
![]() |
1875 | [125I]prolactin-releasing peptide-20 | |||||
psalmotoxin 1 | 4292 | PcTx1 | |||||||
[125I]psalmotoxin 1 |
![]() |
![]() |
4073 | [125I]-PcTx1 | |||||
pseudechetoxin | 2354 | ||||||||
PSMα3 | 6267 | ||||||||
PTH-(1-34) (rat) | 4449 | ||||||||
PTHrP-(1-34) (human) | 1822 | parathyroid hormone-related peptide | |||||||
PTHrP-(7-34) (human, rat, mouse) | 1814 | parathyroid hormone related peptide 7-34 | |||||||
PTHrP-(1-21)/PTH-(22-34) (human) | 1788 | hybrid of human PTHrP and human PTH | |||||||
PTHrP-(1-20)/TIP-(23-39) (human) | 1787 | ||||||||
PWT2-N/OFQ | 8865 | ||||||||
PWT1-NPS | 9167 | ||||||||
[125I](Pyr1)apelin-13 |
![]() |
![]() |
601 | ||||||
[3H](Pyr1)[Met(0)11]-apelin-13 |
![]() |
![]() |
604 | ||||||
[125I]PYY |
![]() |
![]() |
1519 | [125I]peptide tyrosine tyrosine, [125I]peptide YY | |||||
[125I]PYY-(3-36) (human) |
![]() |
![]() |
3802 | [125I]-peptide YY(3-36), [125I]-PYY(3-36) | |||||
PYY-(13-36) (mouse, rat, pig) | 1516 | porcine peptide tyrosine tyrosine (13-36), porcine peptide YY (13-36), rat peptide tyrosine tyrosine (13-36), rat peptide YY (13-36) | |||||||
PYY-(3-36) (pig) | 1543 | porcine peptide tyrosine tyrosine (3-36), porcine peptide YY (3-36) | |||||||
[125I]PYY (pig) |
![]() |
![]() |
1520 | [125I]pPYY | |||||
Q | Back to top | ||||||||
QM107 | 13527 | ||||||||
[125I]QRFP43 (human) |
![]() |
![]() |
3803 | [125I-Tyr-32]-QRFP, [125I]-pyro-glutamylated arginine-amide peptide, [125I]-QRFP | |||||
Qu-SPX | 11419 | ||||||||
QWF |
![]() |
9568 | Boc-Gln-D-Trp(CH0)-Phe-OBzl, Nα-[Nα-[Nα-(tert-butyloxycabonyl)-L-glutaminyl]-N1-formyl-D-tryptophyl-L-phenylalanine benzyl ester | ||||||
R | Back to top | ||||||||
R396 | 2118 | R 396, R-396 | |||||||
R-486 | 2105 | [Trp7,β-Ala8]neurokinin A(4-10), MEN 10295, R 486, R486 | |||||||
R-715 | 661 | [Ac-Lys-[d-βNal7,Ile8]des-Arg9]bradykinin, R 715, R715 | |||||||
R-954 | 3906 | AcOrn[Oic(2),(αMe)Phe(5),dβNal(7),Ile(8)]desArg(9)-bradykinin, R954 | |||||||
RAG8 | 10271 | ||||||||
ranatensin | 618 | ||||||||
rasburicase |
![]() |
7467 | Elitek®, Fasturtec®, SR-29142 | ||||||
RB-400 | 900 | RB 400, RB400 | |||||||
R3 B1-22R | 11461 | ||||||||
R3(BΔ23-27)R/I5 chimeric peptide | 3907 | ||||||||
R3(BΔ23-27)R/I5 chimeric peptide (B chain) | 3909 | ||||||||
relaxin {Sp: Pig} | 1992 | ||||||||
relaxin {Sp: Rhesus macaque} | 1994 | ||||||||
relaxin A chain {Sp: Pig} | 4438 | ||||||||
relaxin A chain {Sp: Rhesus macaque} | 4440 | ||||||||
relaxin B chain {Sp: Pig} | 4439 | ||||||||
relaxin B chain {Sp: Rhesus macaque} | 4441 | ||||||||
relaxin-3 B chain dimer | 8337 | ||||||||
[125I]relaxin-3-B/INSL5 A chimera |
![]() |
![]() |
3789 | [125I]H3-B/INSL5 A chimera | |||||
[125I]relaxin-3 (human) |
![]() |
![]() |
1999 | [125I]H3-relaxin (human) | |||||
[125I]relaxin (human) |
![]() |
![]() |
5398 | [125I]H2 relaxin | |||||
[33P]relaxin (human) |
![]() |
![]() |
1991 | [33P]H2 relaxin (human), [33P]Human gene 2 relaxin | |||||
reltecimod | 13721 | AB 103, AB103, p2TA | |||||||
RES7011 | 3911 | RES 701-1, RES-701-1 | |||||||
resokine | 8736 | aTyr 1920, HisRSN4, HRS(1-60) | |||||||
retatrutide | 13769 | ||||||||
RF9 | 1486 | 1-Adamantanecarbonyl-RF-NH2 | |||||||
[125I]26RFa (human) |
![]() |
![]() |
10253 | ||||||
RgIA4 | 9472 | ||||||||
R5-HIV-1 gp120 | 3910 | ||||||||
Rhodei-litorin | 6165 | rohdeilitorin | |||||||
rho-TIA | 507 | ρ-TIA, ρ-TIA conotoxin, 19-amino acid conopeptide, rho-conotoxin TIA | |||||||
RhTx | 12544 | Tau-scoloptoxin04-Sm1a | |||||||
ΔR3/I5 | 11916 | ||||||||
R3/I5 | 1998 | H3 relaxin B-chain/INSL5 A-chain chimera, H3 relaxin/INSL5 chimera, H3-B/INSL5 A chimera | |||||||
rilonacept |
![]() |
![]() |
6790 | Arcalyst®, IL-1 Trap, interleukin-1 Trap | |||||
R3/I5- SmBiT |
![]() |
11911 | |||||||
RLF-(A11-B10)-isopeptide amideA26 (xA11-B10) | 11922 | ||||||||
Ro 25-1392 | 2276 | Ac-His1[Glu8,OCH3-Tyr10,Lys12,Nle17,Ala19,Asp25,Leu26,Lys27,28]VIP, Ro 251392, Ro251392 | |||||||
Ro 25-1553 | 2259 | Ac-His1[Glu8,Lys12,Nle17,Ala19,Asp25,Leu26,Lys27,28,Gly29,30,Thr31]VIP-NH2(cyclo 21-25), Ro 251553, Ro-251553 | |||||||
romiplostim |
![]() |
![]() |
6974 | MG531, Nplate® | |||||
rotigaptide | 9214 | Dipeptide 9f [PMID 19175320], GAP-134, ZP-123 | |||||||
RSLV-132 |
![]() |
10412 | RSLV132 | ||||||
S | Back to top | ||||||||
S36057 | 1294 | S 36057, S-36057 | |||||||
S36077 | 1295 | S 36077, S-36077 | |||||||
S36539 | 1308 | S 36539, S-36539 | |||||||
S36540 | 1309 | S 36540, S-36540 | |||||||
S36541 | 1310 | S 36541, S-36541 | |||||||
S38151 | 1311 | p-guanidinobenzoyl-[Des-Gly10]-MCH(7-17), S 38151, S-38151 | |||||||
[125I]S36057 |
![]() |
![]() |
1317 | ||||||
sANP | 5053 | natriuretic peptide receptor/guanylyl cyclase A-selective agonist type A naturetic peptide (G9T, R11S, G16R) | |||||||
sarafotoxin S6b | 995 | ||||||||
[125I]sarafotoxin S6b |
![]() |
![]() |
993 | ||||||
sarafotoxin S6c | 1008 | S6C, Sarafotoxin-C, SRTX-C | |||||||
[Sar1,Ala8]Ang-II | 6915 | ||||||||
saralasin | 598 | P-113 | |||||||
[125I][Sar1]Ang-II |
![]() |
![]() |
6897 | ||||||
[Sar1,Cha4]Ang-II | 6903 | ||||||||
[Sar1,Cha8]Ang-II | 6904 | ||||||||
[125I][Sar1, D-Ala8]Ang II |
![]() |
![]() |
12299 | 125I-Sarcosine1, D-Alanine8-Angiotensin II | |||||
[Sar1, D-Ala12]galanin(1-16) | 6082 | [Sar1, D-Ala12]Gal(1-16), AR-M961 | |||||||
[Sar,D-Phe8,des-Arg9]bradykinin | 643 | [N-methylglycine,D-Phe8,des-Arg9]bradykinin, [sarcosine,D-Phe8,des-Arg9]bradykinin, Sar[DPhe8][des-Arg9]BK | |||||||
[Sar1,Gly4,Gly8]Ang-II | 6916 | ||||||||
sargramostim |
![]() |
7905 | Leukine® | ||||||
[Sar1,Ile8]Ang-II | 6905 | ||||||||
[125I][Sar1,Ile8]Ang-II |
![]() |
![]() |
6906 | ||||||
[Sar1,Ile4,Ile8]Ang-II | 6914 | ||||||||
[Sar9,Met(O2)11]SP | 3850 | [Sar9,Met(O2)11]substance P, [Sar9]substance P sulfone | |||||||
SA10SC-RLX | 12501 | ||||||||
sauvagine | 918 | ||||||||
[125I]sauvagine (frog) |
![]() |
![]() |
916 | ||||||
sBmTX 3 | 2584 | sBmTX3-delYP | |||||||
SC-67655 |
![]() |
8889 | |||||||
sCKβ8-1 | 6251 | CKβ8-1 (46-137) | |||||||
α-scorpion toxin 2 | 2618 | α-mammal toxin Lqh2, Lqh II, LqhII, LqTx-2 | |||||||
β-scorpion toxin Cn2 | 2632 | β-mammal toxin Cn2, Toxin 2, Toxin II.9.2.2 | |||||||
β-scorpion toxin Css IV | 2620 | β-mammal toxin Css4, Css IV | |||||||
β-scorpion toxin TiTXγ | 2627 | β-mammal/insect toxin Ts7, Tityustoxin VII, TsTX-VII | |||||||
ScTx1 | 2576 | κ-theraphotoxin-Sc1a, κ-TRTX-Sc1a, stromatoxin-1 | |||||||
SDF1 P2G | 8536 | ||||||||
SDF-1, 1-9[P2G] dimer | 851 | stromal cell-derived factor-1, N-terminal fragment analogue dimer | |||||||
sea anemone toxin BDS-I | 2578 | antihypertensive protein BDS-1, blood depressing substance 1 (BDS-1) | |||||||
secretin {Sp: Pig} | 1155 | ||||||||
secretin-(5-27) (pig) | 1156 | secretin5-27 (porcine) | |||||||
[125I]secretin (pig) |
![]() |
![]() |
1153 | ||||||
seglitide | 2051 | MK 678, MK-678, MK678 | |||||||
selepressin | 11454 | FE202158 | |||||||
semaglutide |
![]() |
9724 | NN-9535, NN9535, NNC0480 0389, Ozempic® (injectable semaglutide), Rybelsus® (oral semaglutide), Wegovy® | ||||||
senktide | 2127 | suc[Asp6,MePhe3]SP(6-11), suc[Asp6,MePhe3]SP(6-11)) | |||||||
[3H]senktide |
![]() |
![]() |
3834 | [3H]-senktide | |||||
septide | 2095 | [pGlu6,Pro9]substance P | |||||||
seractide acetate |
![]() |
6966 | |||||||
[Ser8]GnRH | 1171 | seabream GnRH | |||||||
sermorelin |
![]() |
6998 | Geref®, sermorelin acetate | ||||||
[Ser11](N-CNP,C-ANP)pBNP2-15 | 4853 | P18 | |||||||
setmelanotide |
![]() |
9272 | BIM-22493, Imcivree®, IRC-022493, RM-493 | ||||||
SFLLRN-NH2 | 5361 | ||||||||
SGTx1 | 7761 | κ-theraphotoxin-Scg1a, κ-TRTX-Scg1a, toxin SGTx1 | |||||||
SHAAGtide | 6275 | ||||||||
ShK(L5) | 2557 | ShK-170 | |||||||
ShK Toxin | 2549 | potassium channel toxin ShK, Stichodactyla helianthus toxin | |||||||
SHU9119 | 1325 | (Ac-cyclo-[Nle4Asp5,D-Nal(2)7,Lys10]α-MSH-(4-10)-NH2), SHU 9119, SHU-9119 | |||||||
[125I]SHU9119 |
![]() |
![]() |
3804 | [125I]-SHU9119 | |||||
SI5α-b | 11604 | ||||||||
SiFA-Asn(AcNH-β-Glc)-PEG-Tyr3-octreotate | 5634 | ||||||||
SiFA-Asn(AcNH-β-Glc)-Tyr3-octreotate | 5633 | ||||||||
SKF-105494 | 2229 | SK&F-105494, SKF 105494 | |||||||
SLIGKV-NH2 | 3740 | ||||||||
SLIGRL-NH2 | 3741 | ||||||||
slotoxin | 2310 | Potassium channel toxin α-KTx 1.11, SloTx | |||||||
SNG001 |
![]() |
11129 | |||||||
SNX482 | 4315 | SNX-482, toxin SNX-482 | |||||||
somatrogon |
![]() |
12013 | hGH-CTP, MOD-4023, MOD4023, Ngenla®, somatrogon-ghla | ||||||
SOR-C13 | 12562 | ||||||||
sovateltide |
![]() |
3886 | IRL 1620, IRL-1620, IRL2620, PMZ-1620, SPI-1620, Suc[Glu9,Ala11,15]ET-110-21, Tycamzzi® | ||||||
spantide I | 2096 | [Arg1,Trp7,9,Leu11]substance P, [D-Arg1,D-Trp7,9,Leu11]-Substance P | |||||||
spantide II | 2097 | ||||||||
[125I]spexin-1 |
![]() |
![]() |
11418 | ||||||
[125I]SP (human, mouse, rat) |
![]() |
![]() |
3805 | [125I]-SP, [125I]-substance P | |||||
[3H]SP (human, mouse, rat) |
![]() |
![]() |
3835 | [3H]-SP, [3H]-substance P | |||||
spinorphin | 1026 | LVVYPWT | |||||||
SPR741 | 13250 | NAB741 | |||||||
SQ007-5 | 8379 | ||||||||
s-RhTx | 12546 | ||||||||
SsmTx-1 | 7764 | ||||||||
sst3-ODN-8 | 2077 | carbamoyl-des-AA1,2,4,5,12,13[d-Cys3,Tyr7,d-Agl8(Me,2-naphthoyl)]-somatostatin-14 | |||||||
[125I]Sta |
![]() |
![]() |
4850 | [125I]-Sta | |||||
STM 434 | 8991 | ||||||||
substance P-(4-11) | 2099 | substance P(4-11) | |||||||
substance P-(6-11) | 2100 | substance P(6-11) | |||||||
substance P-OMe | 2101 | SPME, SPOMe, substance P methylester | |||||||
survodutide | 13383 | BI 456906, BI456906 | |||||||
T | Back to top | ||||||||
T134 | 852 | ||||||||
T140 | 853 | [L-3-(2-naphthyl)-alanine3]-T134 | |||||||
T22 | 854 | [Tyr5,12,Lys7]-polyphemusin II | |||||||
tadekinig alfa |
![]() |
10077 | |||||||
TAK 044 | 3913 | TAK-044, TAK044 | |||||||
TAK-448 | 10222 | analogue 24 [PMID: 27589480], RVT-602, TAK448 | |||||||
taliglucerase alfa |
![]() |
7444 | Elelyso®, PRGCD | ||||||
tamapin | 2319 | potassium channel toxin α-KTx 5.4 | |||||||
TamRLX |
![]() |
11462 | |||||||
taspoglutide | 13315 | BIM51077, ITM077, R1583 | |||||||
tatM2NX | 11080 | tat-M2NX | |||||||
[tBaa1,D-Tyr(Et)2,Val4,Lys6,Arg-NH28,des-Gly9]AVP | 2212 | ||||||||
t-Boc-FLFLF | 1030 | ||||||||
t-Boc-Met-Leu-Phe | 1029 | tert-butoxycarbonyl (t-Boc) Met-Leu-Phe peptide | |||||||
[tBu-D-Gly5]NPS | 5812 | ||||||||
[tBu-D-Gly5]NPS | 12489 | ||||||||
TC14012 |
![]() |
2902 | TC 14012, TC-14012 | ||||||
T20(DP178) | 5838 | T20(DP178) [HIV-1 gp41 derived peptide] | |||||||
T21/DP107 | 6245 | ||||||||
teduglutide |
![]() |
![]() |
7049 | ALX-0600, Gattex®, GLP2-2G, Revestive® | |||||
telitacicept |
![]() |
![]() |
11827 | RC18, Tai'ai® | |||||
teriparatide |
![]() |
4448 | Forsteo®, Forteo®, PTH-(1-34) (human) | ||||||
terlipressin |
![]() |
11241 | glycyl-glycyl-glycyl-L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparagyl-L-cysteinyl-L-prolyl-L-lysyl-glycinamide (4->9)-disulfide, Glypressin®, N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin, Terlivaz®, Variquel® | ||||||
tertiapin-Q | 2383 | TPN(Q) | |||||||
[125I]tertiapin Y1/K12/Q13 |
![]() |
![]() |
2382 | ||||||
tesamorelin |
![]() |
6959 | (3E)-hex-3-enoylsomatoliberin, Egrifta®, TH9507 | ||||||
tethered chemerin 9 |
![]() |
9784 | |||||||
β3-tetrapeptide | 2078 | ||||||||
TFLLR-NH2 | 3742 | PEPTIDE1{T.F.L.L.R.[am]}$$$$, Thr-Phe-Leu-Leu-Arg-amide | |||||||
TFRGAP-NH2 | 5360 | ||||||||
TG-0205221 |
![]() |
11176 | Cbz-Thr(tBu)-Cha-Ala(((S)-2-oxopyrrolidin-3-yl))-ol, N-benzyloxycarbonyl-O3-tert-butyl-L-threonyl-3-cyclohexyl-L-alanyl-3-((S)-2-oxopyrrolidin-3-yl)-L-alaninol, TG0205221 | ||||||
THG213.29 | 5860 | ||||||||
[Thi5,8,D-Phe7]bradykinin | 678 | ||||||||
Thr10contulakin-G | 1573 | ||||||||
[Thr4,Gly7]OT | 2179 | [Thr4,Gly7]oxytocin | |||||||
timtraxanib | 11673 | AVI-3207, AVI3207, N2-acetyl-L-arginyl-L-leucyl-L-tyrosyl-L-glutamic acid | |||||||
TIP39-(3-39) (human/bovine) | 1816 | human/bovine tuberoinfundibular peptide 3-39 | |||||||
TIP39-(7-39) (human/bovine) | 1827 | human/bovine tuberoinfundibular peptide 7-39 | |||||||
TIP39-(9-39) (human/bovine) | 1818 | human/bovine tuberoinfundibular peptide 9-39 | |||||||
TIP39-(7-39) (mouse) | 1828 | mouse tuberoinfundibular peptide 7-39 | |||||||
tirzepatide |
![]() |
11429 | LY-3298176, LY3298176, Mounjaro®, Zepbound® | ||||||
T20K | 13239 | ||||||||
TK-HR peptide | 13042 | tachykinin-HR | |||||||
tolyacetyl-c[DCys-Apa-DTrp-Orn-Val-Cys]-His-amide | 2166 | ||||||||
toxin BmP09 | 2306 | B. martensi Karsch toxin, beta-toxin BmKAs1, BmK activator of skeletal-muscle ryanodine receptor | |||||||
TP0556351 | 12057 | compound 9 [PMID: 35687819], TP-0556351 | |||||||
TP508 | 9284 | Chrysalin | |||||||
trans-cinnamoyl-LIGRLO [N-[3H]propionyl]-NH2 |
![]() |
![]() |
3914 | ||||||
trebananib | 8414 | 2xCon4[C], AMG-386, TN8-Con4 | |||||||
[3H]TRH (human, mouse, rat) |
![]() |
![]() |
3836 | [3H]-thyrotropin-releasing hormone, [3H]-TRH | |||||
Tri-DAP | 9507 | L-Ala-γ-D-Glu-mDAP | |||||||
[125I]triptorelin |
![]() |
![]() |
1168 | [125I][D-Trp6]GnRH | |||||
triptorelin |
![]() |
1177 | CL 118532, CL-118532, Decapeptyl®, Pamorelin®, Trelstar®, Triptodur® | ||||||
trofinetide |
![]() |
12482 | ACP-2566, analogue 4 [PMID: 15837309], Daybue®, glycyl-alpha-methyl-L-prolyl-L-glutamic acid, NNZ-2566, NNZ2566 | ||||||
[Trp7, β-Ala8] neurokinin A-(4-10) | 5782 | ||||||||
[Trp8]GnRH | 1172 | frog GnRH | |||||||
Trp11-neurotensin | 1585 | ||||||||
[Trp23]PTHrP-(1-36) (human) | 1809 | ||||||||
trptorelix-1 | 3916 | Trp-1 | |||||||
[Trp23,Tyr36]PTHrP-(1-36)-NH2 (human) | 1808 | ||||||||
TRV023 | 11943 | TRV 023, TRV-023 | |||||||
TRV026 | 11944 | TRV 026, TRV-026 | |||||||
TRV027 | 6902 | TRV 120027, TRV-027, TRV-120027, TRV120027 | |||||||
[125I]TSH (human) |
![]() |
![]() |
3806 | [125I]-thyroid-stimulating hormone, [125I]-thyrotropin, [125I]-TSH | |||||
[125I]Tyr-Ala-hexarelin |
![]() |
![]() |
1095 | ||||||
[125I][Tyr4]bombesin |
![]() |
![]() |
623 | [125I-Tyr4]BN | |||||
[125I][Tyr8]bradykinin |
![]() |
![]() |
3765 | [125I]-[Tyr8]-bradykinin, [125I]-[Tyr8]BK, [125I][Tyr8]BK | |||||
[Tyr8]bradykinin | 671 | [Tyr8]BK | |||||||
Tyr0α-CGRP (human) | 692 | Tyr0α-calcitonin gene-related peptide (human) | |||||||
[125I]Tyr0-CRF (human, rat, mouse) |
![]() |
![]() |
914 | [125I]-Tyr0-corticotropin | |||||
[125I]Tyr10-CST14 |
![]() |
![]() |
2024 | [125I]-[Tyr10]CST-14, [125I]Tyr10-cortistatin14 | |||||
[125I][Tyr5,DAla6,NMeLeu7,Pro9-NEt]GnRH |
![]() |
![]() |
1165 | ||||||
[125I][Tyr11]des-Br-NPB-23 |
![]() |
![]() |
1498 | [125I][Tyr11]des-Br-neuropeptide B-23 | |||||
[125I]Tyr4-des-octanoyl-ghrelin |
![]() |
![]() |
3810 | [125I]-Tyr4-des-octanoyl-ghrelin | |||||
[125I][Tyr26]galanin (human) |
![]() |
![]() |
5391 | [125I]-[Tyr26]galanin | |||||
[125I][Tyr26]galanin (pig) |
![]() |
![]() |
6117 | ||||||
[125I][Tyr26]galanin (rat/mouse) |
![]() |
![]() |
5390 | [125I]-[Tyr26]galanin | |||||
[125I][Tyr4]ghrelin (human) |
![]() |
![]() |
1096 | [125I-Tyr4]-ghrelin, [125I-Tyr4]ghrelin | |||||
[Tyr34]GLP-2 (human) | 1145 | human [Tyr34] glucagon-like peptide 2 | |||||||
[Tyr8]GnRH | 1173 | ||||||||
[125I]Tyr45-kisspeptin-15 |
![]() |
![]() |
1280 | [125I-Tyr45]-KP15, [125I-Tyr45]kisspeptin-15, [125I-Tyr45]KP-15 | |||||
[3H]Tyr14-N/OFQ |
![]() |
![]() |
1687 | [3H]14-Tyr-N/OFQ, [3H]14-Tyr-nociceptin, [3H]14-Tyr-nociceptin/orphanin FQ, [3H]14-Tyr-orphanin FQ | |||||
[125I]Tyr10NPS (human) |
![]() |
![]() |
1493 | human [125I]Tyr10-neuropeptide S | |||||
Tyr3-octreotide | 5649 | SMS 204,090, TOC, Tyr3-SMS 201,995 | |||||||
[Tyr34]PTH-(1-34) (human) | 1810 | ||||||||
[Tyr34]PTH-(1-34)-NH2 (human) | 1811 | ||||||||
[Tyr34]PTH-(3-34)-NH2 (human) | 1812 | [Tyr34]-PTH 3-34-NH2 | |||||||
[Tyr36]-PTHrP-(1-36) amide (human) | 1813 | [Tyr36]-PTHrP 1-36 amide | |||||||
[125I]Tyr0-sauvagine |
![]() |
![]() |
5389 | [125I]-Tyr0-sauvagine | |||||
[125I](Tyr10)secretin-27 (rat) |
![]() |
![]() |
3759 | [125I]-(Tyr10)secretin | |||||
[125I]Tyr3 SMS 201-995 |
![]() |
![]() |
2062 | [125I][Tyr3]octreotide | |||||
[125I]Tyr11-SRIF-14 |
![]() |
![]() |
2060 | [125I]Tyr11-SS-14 | |||||
[125I]Tyr7-Sst3-ODN-8 |
![]() |
![]() |
2075 | ||||||
[125I][Tyr3,Thr8]octreotide |
![]() |
![]() |
5630 | [125I]-TOCA, [125I]-Tyr3-octreotate | |||||
U | Back to top | ||||||||
UFP-101 | 1694 | [Nphe1,Arg14,Lys15]N/OFQ-NH2, [Nphe1,Arg14,Lys15]nociceptin-NH2, UFP 101, UFP101 | |||||||
UFP-102 | 1685 | [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2, UFP 102, UFP102 | |||||||
UFP-112 | 3917 | [(pF)Phe4Aib7Arg14Lys15]N/OFQ-NH2, UFP 112, UFP112 | |||||||
Ugr 9-1 | 11475 | π-AnmTX Ugr 9a-1 | |||||||
[125I]U-II (human) |
![]() |
![]() |
2158 | human [125I-Tyr9] urotensin-II, human [125I] urotensin-II | |||||
U-II-(4-11) (human) | 2152 | human urotensin-II (4-11) | |||||||
ularitide | 8446 | ESP-305 | |||||||
uPar fragment | 6249 | D2D388-274, uPAR(88-274) | |||||||
urantide | 2167 | [Pen5,DTrp7,Orn8]U-II (4-11) (human) | |||||||
[125I]urocortin 1 (mouse, rat) |
![]() |
![]() |
917 | ||||||
Urolinin | 9441 | ||||||||
urotensin 1 (fish) | 922 | ||||||||
V | Back to top | ||||||||
[Val4]AVP | 2180 | VDAVP, 4-Val-argipressin | |||||||
valspodar | 11745 | 3'-keto-Bmt(1)-Val(2)-cyclosporin A, Amdray®, PSC-833, PSC833, SDZ PSC 833, SDZ PSC833, SDZ-PSC-833 | |||||||
vanillotoxin-1 | 5542 | tau/kappa-theraphotoxin-Pc1a, tau/kappa-TRTX-Pc1a, VaTx1 | |||||||
vanillotoxin-2 | 5543 | tau-theraphotoxin-Pc1b, tau-TRTX-Pc2a, VaTx2 | |||||||
vanillotoxin-3 | 5544 | tau-theraphotoxin-Pc1c, tau-TRTX-Pc1c, VaTx3 | |||||||
vapreotide |
![]() |
2054 | BMY 41606, CCRIS 6495, RC 160, RC-160, Sanvar®, vapreotide acetate | ||||||
variant MCH | 1302 | variant melanin-concentraing hormone | |||||||
vCCL4 | 774 | viral CCL4 | |||||||
vCXCL1 | 8496 | ||||||||
velaglucerase alfa |
![]() |
7464 | EC 3.2.1.45, VPRIV® | ||||||
veldoreotide | 8487 | COR-005, DG3173, PTR-3173, somatoprim | |||||||
[125I]VIP (human, mouse, rat) |
![]() |
![]() |
2277 | [125I]-VIP, [125I]vasoactive intestinal peptide | |||||
Vm24 |
![]() |
10050 | α-KTx 23.1 | ||||||
vMCC-I | 816 | MCV MC148R | |||||||
vMIP-I | 815 | HHV8 vMIP-I, viral macrophage inflammatory protein | |||||||
vMIP-II | 768 | vMIP-II, viral macrophage inflammatory protein-II | |||||||
vMIP-III | 4359 | HHV8 vMIP-III, KSHV vMIP-III | |||||||
voclosporin |
![]() |
![]() |
11388 | 1,11-anhydro[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl- N-methyl-L-valyl-[(2S,3R,4R,6E)-3-hydroxy-4-methyl- 2-(methylamino)nona-6,8-dienoyl][(2S)-2-aminobutanoyl]- N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine], E-ISA247, ISA(TX)247, ISA-247, ISA247, ISATX247, Lupkynis®, R 1524, R-1524, R1524 | |||||
vosoritide |
![]() |
9068 | BMN 111, BMN-111, Voxzogo® | ||||||
V3 peptide | 6248 | ||||||||
W | Back to top | ||||||||
waglerin-1 | 3984 | ||||||||
wFw-Isn-NH2 | 5869 | ||||||||
WKYMVm |
![]() |
1048 | Trp-Lys-Tyr-Met-Val-[D]Met, WKYMVM | ||||||
WRWWWW |
![]() |
1040 | WRW4 | ||||||
WWGKKYRASKLGLAR | 5760 | ||||||||
X | Back to top | ||||||||
[125I]XCL1 (human) |
![]() |
![]() |
857 | [125I]ATAC, [125I]lymphotactin, [125I]SCM-1α | |||||
X4-HIV-1 gp120 | 3919 | X4 human immunodeficiency virus type 1 gp120 | |||||||
Y | Back to top | ||||||||
YH35324 |
![]() |
13448 | IgETRAP, YH-35324 | ||||||
YJ34 | 8722 | ||||||||
Y-KE88 | 5641 | ||||||||
[125I]Y-RFRP-3 |
![]() |
![]() |
1484 | [125I]YVP | |||||
Y-RFRP-3 | 1482 | YVP | |||||||
YSFKPMPLaR | 5776 | C5a65-74Y65,F67,P69,P71,D-Ala73 | |||||||
Z | Back to top | ||||||||
Z-Arg-Leu-Val-Agly-Ile-Val-OMe | 6534 | ||||||||
Z-AVLD-FMK | 11712 | ||||||||
Z-DEVD-FMK | 5294 | benzyloxycarbonyl-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fluoromethylketone | |||||||
Z-DQMD-FMK | 5295 | benzyloxycarbonyl-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone | |||||||
Z-FA-FMK |
![]() |
11257 | MDL 201053, MDL-201053, MDL201053, Z-Phe-DL-Ala-fluoromethylketone, ZFA-fmk | ||||||
ziconotide |
![]() |
2536 | ω-conotoxin MVIIA, Prialt®, SNX-111 | ||||||
Z-IETD-FMK | 5296 | ||||||||
zilucoplan |
![]() |
![]() |
10404 | RA-101495, RA101495, Zilbrysq® | |||||
Z-LEHD-FMK | 5298 | benzyloxycarbonyl-Leu-Glu(OMe)-His-Asp(OMe)-fluoromethylketone | |||||||
Z-VDVAD-FMK | 5299 | benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethylketone | |||||||
Z-VEID-FMK | 5300 | benzyloxycarbonyl-Val-Glu(OMe)-Ile-Asp(OMe)-fluoromethylketone | |||||||
Z-WEHD-FMK | 5301 | benzyloxycarbonyl-Trp-Glu(OMe)-His-Asp(OMe)-fluoromethylketone | |||||||
zyklophin | 9193 | ||||||||
Z-YVAD-FMK | 5302 | benzyloxycarbonyl-Tyr-Val-Ala-Asp(OMe)-fluoromethylketone, caspase-1 Inhibitor VI | |||||||
ZZL-7 | 12316 | Ac-Ala-Val-Ome | |||||||